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Computational modeling analysis of mitochondrial superoxide 
production under varying substrate conditions and upon 
inhibition of different segments of the electron transport chain
Nikolai I. Markevich1,2,* and Jan B. Hoek1
1MitoCare Center for Mitochondrial Research, Department of Pathology, Anatomy, and Cell 
Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA
2Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 
Moscow region 14290, Russia
1. Introduction
Accumulating evidence over the past decades has demonstrated that reactive oxygen species 
(ROS), such as superoxide, hydrogen peroxide and other reactive forms of oxygen, are 
critical mediators in a broad range of cellular signaling processes [1, 2]. However, their 
production must be carefully controlled as the oxidative stress associated with uncontrolled 
ROS formation can cause damage to proteins, lipid membranes and DNA. ROS-induced cell 
and tissue injury plays a role in a broad range of disease conditions, from cancer to ischemic 
cardiac injury and stroke to neurodegenerative diseases and other age-related degenerative 
conditions [2, 3]. Understanding how cells are protected against oxidative stress damage 
requires an understanding both of processes that contribute to ROS formation and of 
oxidative stress defense capacities and cellular repair mechanisms.
The mitochondrial electron transport chain is one of the major contributors to ROS 
formation in most cells. Early studies by Chance and coworkers [4] had demonstrated that 
mitochondria generate H2O2 at a rate that is dependent on the respiratory substrate and 
oxygen levels and is influenced by the respiratory state and the presence of inhibitors of the 
electron transport chain. Work by many investigators has since confirmed that Complexes I 
and III of the mitochondrial respiratory chain are major sources of reactive oxygen species 
(ROS) in the cell, primarily generated in the form of superoxide . However, in spite of 
intensive biochemical and biophysical studies of electron and proton transfer in different 
segments of the electron transport chain (for reviews, see [5–9] ) numerous questions about 
the mechanisms of  generation remain unresolved. One of these is the identification of 
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sites of  formation in Complex I. There is a consensus that reduced FMNH− is one site of 
O2 reduction by Complex I [5]. However, experimental data on the rate of ROS production 
by Complex I in mitochondria mediating forward and reverse electron transport show that at 
least one more site of  production in complex I should be considered in order to account 
for experimental observations (for review see [6]). The Q-binding site was suggested as a 
site of superoxide formation in Complex I [7, 9, 10].
Another key unresolved question concerns the mechanism of bifurcated oxidation of 
ubiquinol at the QO site of complex III, especially the initiation of movement of the reduced 
Rieske iron-sulfur protein (ISPH) from the QO site to cyt c1 [11]. While the crystal structure 
of Complex III is well established, there is no consensus about the exact sequence of 
dissociation of ISPH from the QO site and transfer of the second electron to cyt bL. Crofts 
and colleagues [8, 12] suggested that dissociation of the reduced ISPH from the QO site, 
with further transfer of the first electron to cyt c1, occurs before transfer of the second 
electron from semiquinone to cyt bL (early ISPH dissociation). Other authors [11, 13–16] 
proposed that ISPH dissociates from the QO site only after transfer of the second electron 
from semiquinone to cyt bL and cyt bH, i.e. after cyt bH reduction (late ISPH dissociation), 
which may be an important mechanism to protect Complex III from short-circuiting when 
both electrons transfer from QH2 into the high potential c-chain. For a more detailed 
discussion of the arguments supporting one or the other hypothesis see [8, 11–13].
In addition, many questions related to ROS production upon inhibition of different segments 
of the respiratory chain remain unresolved. For instance, Brand and coworkers [17] showed 
recently that their experimental data on the rate of superoxide production by the antimycin-
inhibited Complex III can be accounted for only by the assumption that the rate constants of 
ubiquinol oxidation at the Qo site are very low if cyt bL is in the reduced state, which 
implies a complex dependence of binding QH2 and Q to the Qo site on the redox state of cyt 
bL. Another interesting feature first observed by Drose and Brandt [18] in submitochondrial 
particles and purified cytochrome bc1 complex from bovine heart mitochondria is the non-
monotonic dependence of ROS production by antimycin-inhibited Complex III on the 
activity of succinate dehydrogenase and the concentration of the oxidized ubiquinone Q. In 
order to account for an unexpected decrease in ROS production by antimycin-inhibited 
Complex III with increasing the QH2/Q ratio (an increase in ROS production with increasing 
oxidized ubiquinone Q) Drose and Brandt [18] proposed that oxidized ubiquinone supports 
ubisemiquinone formation and, respectively, superoxide production at the Qo site due to 
transfer of electrons from reduced cytochrome bL onto Q in a reverse reaction of the Qo site. 
Later, this hypothesis was confirmed and studied in more detail experimentally in isolated 
mitochondria from skeletal muscle and with the help of a computational model by Brand 
and coworkers [17], who showed non-monotonic dependencies of ROS production by 
antimycin-inhibited Complex III on the concentration of different respiratory substrates for 
Complexes I and III and the reduced cyt bL. These experimental and computational 
modeling results show that reverse reactions at the Qo site can play an important role in 
ROS formation by antimycin-inhibited Complex III and should be taken into account in 
studies of ROS production by the entire electron transport chain (ETC) with and without 
inhibitors of different segments of ETC.
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Such questions are not unexpected for a system as complex as the respiratory chain, the 
analysis of which is difficult when based just on experimental studies. A computational 
systems biology approach can be helpful in these analyses, the starting point for which is a 
detailed computational model of the entire respiratory chain. Such a computational 
mechanistic model of electron transfer and superoxide formation in the mitochondrial 
respiratory chain, through which different hypotheses can be evaluated, is developed in the 
present study. In contrast to the rule-based model of the respiratory chain [19, 20], we 
applied a standard kinetic approach used previously for computational modeling of Complex 
III and the entire ETC [21–26] with an explicit presentation of the most important pathways 
of electron transfer in Complexes I and III. Besides, in order to explore possible differences 
in responses of ROS production in models taking into account the hypotheses mentioned 
above, pathways of electron transfer and superoxide formation in Complexes I and III were 
considered in more detail compared to other segments of the ETC . The model was analyzed 
under different conditions (forward and reverse electron transport, with and without 
different inhibitors of Complexes I and III) to account for available experimental data on 
ROS production, discriminate between different hypotheses and make predictions to be 
tested experimentally.
2. Methods and Models
2.1. Kinetic model of mitochondrial respiratory chain
A kinetic scheme of electron transfer and superoxide anion  production underlying a 
mechanistic computational model of the mitochondrial respiratory chain is presented in Fig. 
1, modified from a preliminary scheme presented in [27]. This simplified kinetic scheme 
includes the following electron carriers: a) for Complex I (NADH dehydrogenase, also 
known as NADH:Ubiquinone Oxidoreductase): flavine mononucleotide (FMN), the 
sequence of iron-sulfur clusters beginning with N3 and N1a and ending with the N2 cluster, 
and coenzyme Q; b) for Complex III (Cytochrome bc1 complex, also known as 
Ubiquinol:Cytochrome c Oxidoreductase): coenzyme Q, non-heme iron-sulfur protein (ISP), 
cytochromes bL, bH and c1; c) Cytochrome c, and d) Complex IV (Cytochrome c oxidase). 
Complex II (Succinate dehydrogenase) and Complex IV are included as unresolved 
complexes, since these are not generally considered to be direct sources of ROS during 
mitochondrial electron transport. Electron transfer in Complexes I and III is described in 
detail in order to take into account the electron carrier states responsible for bypass 
reduction of O2 resulting in  formation. These bypass reactions are marked in red in the 
kinetic scheme (Figs. 1–2). The entire reaction network of electron transfer and superoxide 
production corresponding to this kinetic scheme in Fig. 1 consists of 40 reactions, the rate 
constants of which are described in detail in Table 1.
2.1.1. Kinetic model of Complex I—The initial steps of electron transfer in Complex I 
(reactions (1–5)) were taken from the kinetic model developed by Kussmaul and Hirst [28] 
for isolated Complex I. These authors proposed that  is formed by the transfer of one 
electron from the fully reduced flavin FMNH− to O2 (reaction (16) in Fig. 1 and Table 1). A 
detailed analysis of NADH/NAD+ binding to Complex I is reviewed by Vinogradov [29]. 
Some kinetic constants of NADH oxidation coupled to the reduction of molecular oxygen 
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were assessed at the suggestion of a ping-pong mechanism [30]. More recently, it was 
shown that the kinetics of NADH oxidation and ubiquinone (Q) reduction in Complex I may 
not obey the classical ordered or ping-pong mechanism due to a strong spatial separation of 
these reactions and the presence of a buffer zone consisting of a chain of Fe-S redox centers 
between NADH- and Q-binding sites [31]. Moreover, using a fitting procedure, the authors 
[31] estimated rate constants of Q (QH2) and NADH (NAD+) binding to Complex I, as well 
as of electron tunneling between different redox centers, with the help of a stochastic model 
of Complex I, with the suggestion of a more complex mechanism taking into account the 
possible diffusion of quinone inside a broad ubiquinone binding pocket. In particular, within 
the framework of this model, the authors could account for an unusual experimental 
observation of substrate inhibition of Q reduction at high Q concentrations.
In the model presented here, for the kinetic description of electron transfer through the chain 
of Fe-S clusters we took into account the generally accepted suggestion that 
FMNH− donates the first electron to the Fe-S cluster N3 (reaction (6)). Electron transfer 
from N3 to the terminal cluster N2 through the chain of equipotential redox centers N1b, 
N4, N5, N6a, and N6b [5, 32] is approximated as a single step (reaction (7)) with an 
apparent rate constant of 104 s−1 since electron movement through the entire chain takes 
about 100 µs [33, 34]. Subsequently, the first electron transfers from N2 to oxidized 
ubiquinone Q bound to Complex I (reactions (8), (9)), reducing ubiquinone to semiquinone.
The second electron transfers from the semireduced flavin radical FMNH· to either cluster 
N1a or cluster N3 (reactions (10) and (11)). Electron transfer from cluster N1a to cluster N3 
is very slow (kforward is about of 160 s−1 [35]) compared to other reactions in Complex I. 
Therefore, we propose that cluster N1a only reversibly deposits single electrons without 
their delivery to the chain of seven redox centers. The kinetic model of electron transfer in 
the membrane domain of Complex I and the coupling mechanism of proton translocation 
through the membrane takes into account recent X-ray structures of complex I and the 
hypothesis of a “piston” mechanism of transmembrane H+ movement, as reported by 
Sazanov and colleagues [36]. It is very likely, in accord with this mechanism, that 3 H+ 
move through the mitochondrial membrane simultaneously (through transmembrane 
subunits NuoL, NuoM and NuoN) during electron transfer from N2 to quinone. We assume 
that a conformational switch and translocation of 3 H+ occurs during electron transfer from 
reduced N2− to ubisemiquinone to form QH2 (reaction (13)) reflecting the experimentally 
observed increase in ubisemiquinone concentration upon an increase in ΔµH+ [37, 38].
The path of the fourth proton translocation in Complex I is not clear [36]. It is very likely 
that the fourth proton transfer is also controlled by a conformational switch in the membrane 
arm [39]. The ROS production rate in Complex I and the redox state of flavin during 
oxidation of NAD-linked substrates don’t depend on the membrane potential in the presence 
of the quinone-binding site inhibitor rotenone [40, 41]. This implies that translocation of the 
fourth H+ is also controlled by electron transfer from N2 to quinone or semiquinone in the 
quinone-binding pocket. We propose that the fourth H+ translocation is also coupled with 
electron transfer from reduced N2− to semiquinone (reaction (13)). Therefore, we suggest 
that 4 H+ move through the mitochondrial membrane simultaneously in reaction (13).
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Reactions (8) and (14) in Fig.1 and Table 1 describe binding and dissociation of Qn and 
QH2n, respectively, in the quinone-binding site, where the subscript “n” refers to the 
negative side of the inner membrane.
Furthermore, we hypothesize that semiquinone in complex CI.Q•− (Fig. 1 and Table 1) is the 
second site of  formation in Complex I (reaction (17)). This hypothesis is supported by 
numerous lines of experimental evidence that ubisemiquinone can be one of the sites of 
superoxide generation in Complex I (for reviews see [6], [42]).
2.1.2. Kinetic model of Complex III—Fully reduced quinone QH2n generated by 
Complex I or Complex II (reaction (19)) translocates to the positive side of the inner 
membrane (reaction (19)), and QH2p is doubly oxidized at the Qo site of Complex III 
(reactions (22–26)). Then, oxidized Qp is transported from the positive to the negative side 
of the inner membrane (reaction (20)), and Qn is doubly reduced at the Qi site of Complex 
III (reactions (32–36)) completing Mitchell’s Q-cycle [43] after binding and oxidation of the 
second QH2p molecule at the Qo site.
The kinetic scheme of QH2p oxidation at the Qo site presented in Fig. 1 is based mainly on 
the work of Crofts and colleagues [8, 12]. These authors suggested the initial formation of 
the ternary complex of cyt bL, QH2p and oxidized Rieske iron-sulfur protein, ISPox, 
(complex bL.QH2.ISPox in Fig. 1) at the Qo site (reaction (22)) with the following 
bifurcated reaction where the first electron of QH2 is transferred to the high-potential chain, 
consisting of ISP (reaction (23)) and cyt c1 (reaction (27)). The second electron is 
transferred from the semiquinone Q·− to the low-potential chain, consisting of cyt bL 
(reaction (24)) and cyt bH (reaction (25)). Electron transfer from the reduced Rieske iron-
sulfur protein ISP (designated as ISPH in Fig. 1) occurs due to movement of the mobile 
extrinsic (or head) domain of ISP (ISP-ED) between the cyt b and c1 positions that are 
defined as ISP-ED bound to the QO site and the ISP-ED position close to the c1 subunit, 
respectively [11, 44]. The states of ISP corresponding to a different position of the ISP-ED 
are designated in Figs. 1 and 2 as different complexes of ISPox and ISPH, where ISPox and 
ISPH mean the oxidized and reduced states of ISP-ED. The states of ISP with some 
intermediate position of ISP-ED between the b- and c1 sites are designated in Figs. 1 and 2 
as free forms of ISPox and ISPH. Therefore, the description in the text of conformational 
changes in the states of ISPox or ISPH implies the domain movement of oxidized or reduced 
ISP-ED.
Crofts and colleagues [8, 12] proposed that ISPH moves from the b-position to the c1-
position (reaction (24)) before the second electron passes to cyt bL. This is the basic kinetic 
scheme which relates to Tables 1 and 2. However, another hypothesis [11] suggests that the 
conformational switch of ISPH occurs only after the second electron transfers from cyt bL to 
bH. For comparison, the kinetic scheme of Complex III with the late ISPH dissociation is 
presented in Fig. 2A. The reaction network of electron transfer and superoxide production 
corresponding to this kinetic model of Complex III with the late ISPH dissociation (model 
L) consists also of 40 reactions, the rate constants of which are described in detail in 
Supplemental materials (Tables S1 and S2). In addition, we will consider the hypothesis 
proposed by Drose and Brandt [18] that oxidized coenzyme Q can leave the Qo site before 
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electron transfer from bL to bH occurs (reaction (41) in the modified kinetic scheme 
presented in Fig. 2B: bL−.Q.ISPH = bL−.ISPH+ Qp). This modified branched kinetic scheme 
of the Q-cycle takes into account the consecutive release of Q and ISPH from the Qo site 
and differs from the kinetic scheme presented in Fig. 2A by additional reactions (41), (42), 
(25a) and (34a). We will analyze all three hypotheses in the Results and Discussion section 
in order to reveal if one of these can account more effectively for available experimental 
data on ROS production.
Based on direct experimental observations [45] it is generally accepted that the unstable 
semiquinone of the Qo site (complex bL. Q·−) is the site of  formation in Complex III. 
This  is released to the IMS and matrix (reactions (28), (29)) [46]. The mechanism of 
separation of  fluxes to these compartments at the Qo site is unclear. For the sake of 
simplicity, we assumed that the rate constants of  release into the IMS and matrix are 
equal.
It should be pointed out, that in the development of the kinetic models of Complex III 
presented in Fig. 1, 2 we combined some experimentally observed individual reactions in 
one overall reaction, for instance, reactions (22) and (23) in all models and additionally 
reaction (26) in the model in Fig. 2A. The main reason for this was to reduce the number of 
model parameters, e.g. the rate constants of the individual reactions comprising a single 
reaction, absolute values of which are known only very approximately, and thereby exclude 
the intermediate states of these reactions that, in our opinion, are not critical for the analysis 
of ROS production (i.e., reaction (22) in all models and reaction (26) in the model of Fig. 
2A). We understand that this simplification may result in some deviation of modeling the 
dependency of ROS production on different factors from that observed experimentally. 
Especially, this relates to the first electron transfer in reaction (23), which occurs according 
to a proton-first-then-electron mechanism [12]. This mechanism implies an initial formation 
of protonated semiquinone QH at the Qo site that can also participate in superoxide 
production. However, little is known about the pK values of QH [12], which is needed for a 
more detailed modeling of the first electron transfer. We believe that, taken together these 
simplifications in the models of Complex III may affect the computational modeling results 
on ROS production quantitatively, but not qualitatively. However, a more detailed 
consideration of some of these reactions, especially the first electron transfer, will be needed 
for a more exact quantitative description of the dependency of ROS production on these 
different factors.
2.2. Computational models of electron transfer in mitochondrial respiratory chain
Computational models consisting of 32 ordinary differential equations (ODEs) for the 
kinetic models presented in Figs. 1 and 2A and 34 ODEs for the branched model in Fig. 2B, 
plus 12 moiety conservation equations, were derived from the reaction networks using the 
law of mass action, Michaelis (more exactly: Henri-Michaelis-Menten [47]) and Hill 
equations for all 40 (44 for the branched model) kinetic processes. All equations are 
presented in Supplemental materials. The models were implemented in DBSolve Optimum 
software available at website http://insysbio.ru . The details of the mathematical model 
describing oxidized and reduced states of different carriers and electron flows through 
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Complexes I, II, III and IV are presented in Supplementary materials. Values of model 
parameters, rate constants and concentration of different electron carriers were taken from 
experimental data in the literature on thermodynamics and kinetics of electron transfer in the 
respiratory chain (Tables 1 and 2 and Supplemental Tables S1–S4).
Dimension of local and whole mitochondrial concentrations and rates—
Experimental data on intramembrane protein concentrations presented in Table 2 are usually 
presented in nmole/mg mitochondrial protein, whereas we use concentration units (µM) in 
our computational model. Moreover, we use in the model local concentrations of proteins in 
different compartments of mitochondria, normalized by the relative volume fractions of 
these compartments. Therefore, NADH and matrix superoxide concentrations were 
normalized by the matrix water volume (VMX), cyt c and superoxide concentrations in the 
intermembrane space (IMS) were normalized by the IMS water volume (VIMS), and 
concentrations of all intramembrane proteins of the respiratory chain were normalized by the 
inner membrane volume (VIMB). First, we normalized the concentration of all proteins by 
the total mitochondrial volume, VMIT; then, total mitochondrial concentrations were 
translated into local concentrations using the water space fraction of matrix (WMX=VMX/
VMIT) and IMS (WIMS=VIMS/VMIT), and the fractional volume ratio of inner membrane 
(WIMB=VIMB/VMIT) to the total mitochondrial volume. In order to calculate WMX, WIMS 
and the total mitochondrial water space fraction, WMITW=VMITW/VMIT, where VMITW is 
the total mitochondrial water volume, we used the following experimental data. The 
mitochondrial water weight fraction, mw/mmit, where mw and mmit is the mass of 
mitochondrial water and mitochondria, respectively, equals 0.664 g/g wet weight for a total 
mitochondrial density, ρmit, (ρmit =mmit / VMIT) of 1.09 g/ml [48]. Because mw = ρw · 
VMITW and mmit = ρmit · VMIT, where the water densities, ρw, and ρmit are 1 and 1.09 g/ml, 
respectively, we can calculate the total mitochondrial water space fraction, WMITW. Since 
mw/mmit = ρw · VMITW / ρmit · VMIT = WMITW · 1 g/ml/1.09 g/ml =0.664 g/g, the total 
mitochondrial water space fraction, WMITW, equals 0.664 · 1.09=0.724.
Taking into account that WIMS ≈ 1/14 ≈ 0.07 of the total mitochondrial water space for the 
orthodox configuration [49], the matrix water space fraction WMX = WMITW - WIMS = 
0.652. These values of WIMS and WMX are in agreement with those used in [50]. The value 
of WIMB was calculated as follows: The volume and inner membrane surface area of an 
average rat liver mitochondrion are 0.27 µm3 and 6.47 µm2, respectively [51]. Assuming an 
average inner membrane thickness of about 0.01 µm, VIMB=6.47 µm2 · 0.01 µm = 0.0647 
µm3 and the inner membrane space fraction (WIMB=VIMB/VMIT) of a mitochondrion is 
approximately 0.24.
The mitochondrial protein weight fraction Wwprot is about 0.25 g/g wet weight [48], i.e., 1 
mg mitochondrial protein corresponds to 4 mg mitochondrial wet weight and occupies 4mg/
1090 mg/ml = 3.67·µl. Therefore, a mitochondrial content of any metabolite of 1 nmol/mg 
mitochondrial protein, when normalized to total mitochondrial volume, is equal to a 
concentration of 10−9 mole/ 3.67·10−6 1 = 273 µM, i.e. 1 µM = 3.67 pmol/mg mitochondrial 
protein.
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In order to obtain local concentration of different proteins in the matrix, IMS and inner 
membrane, the total mitochondrial concentrations were divided by their volume fractions, 
WMX, WIMS and WIMB, respectively. Thus, total local intramembrane concentrations of 
ubiquinone (Q) and Complexes I and III had the following values: total Q = 4 nmol/ mg mit 
prot = 4541 µM; ISP = cyt bL = cyt bH = cyt c1=0.325 nmol/ mg mit prot = 369 µM; 
FMN=N3=N1a=N2=0.2 nmol/ mg mit prot = 227 µM.
In order to present computer simulated rates of respiration and ROS production, which occur 
only in the inner membrane, in units of whole mitochondrial rates we multiplied all the rates 
of intramembrane processes by WIMB = 0.24. In addition, in order to compare computer 
simulated rates of respiration and ROS production presented in the current paper in µM/s 
with experimentally observed rates expressed in pmol/min/mg protein the computer 
simulated rates can be multiplied by a factor of 3.67*60 = 220, i.e. 1 µM/s = 220 pmol/min/ 
mg mitochondrial protein.
3. Results and Discussion
3.1. ΔΨ and ΔpH dependency of the ROS production rate with different respiratory 
substrates
ΔΨ dependency—Experimental observations show that the rate of ROS generation by 
Complexes I and III depends on the respiratory substrates that serve as fuel for Complexes I 
and III (for review see [6]). As a rule, the ROS production rate is low when only NADH-
linked substrates are available, and this rate can be augmented by rotenone. A much higher 
ROS production rate by Complex I is observed in the presence of succinate alone, due to 
reverse electron transport, which is diminished by rotenone. Combined use of succinate and 
NAD-linked substrates results in an increase in the ROS production rate compared to NADH 
alone and a decrease in ROS production compared to succinate alone. In general, the rate of 
ROS production under different conditions changes as follows: (succinate + rotenone) < 
NADH alone < NADH + rotenone < NADH + succinate < succinate alone < succinate + 
Antimycin A. However, some experimental observations show that these relationships can 
change. For instance, in rat brain mitochondria ROS production in the presence of succinate 
alone is less than with NADH + rotenone [52, 53], in bovine heart submitochondrial 
particles, succinate alone and NADH + succinate are less than NADH + rotenone [54]. One 
of the reasons for these differences may be the very high sensitivity of the ROS production 
rate to changes in membrane potential ΔΨ observed experimentally [55–57] and 
theoretically with the help of a simplified computational model of ETC [23].
Our computational modeling results confirm the high ΔΨ sensitivity of the ROS production 
rate and predict that the relationships mentioned above when using different respiratory 
substrates can change due to changes in ΔΨ. Fig. 3 presents the computer simulated steady 
state ΔΨ dependency of the ROS production rate at different sites of Complex I (Fig. 3A, B) 
and Complex III (Fig. 3C) as well as for the entire respiratory chain (Fig. 3D). These 
findings are in essential agreement with recently published modeling results for cardiac 
mitochondria [23] and experimental data on ΔΨ dependency of ROS production by isolated 
mitochondria during oxidation of succinate alone [57] and NADH-linked substrates [55] and 
by isolated Complex III (cytochrome bc1 complex) reconstituted into phospholipid vesicles 
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[56]. For example, the computer simulated dependence of the total superoxide generation 
rate on membrane potential during oxidation of NADH alone presented in Fig. 3D is very 
close qualitatively and quantitatively to the experimentally observed ΔΨ dependency of the 
rate of H2O2 production during oxidation of glutamate + malate or α-ketoglutarate in 
isolated brain mitochondria (Fig. 1 in [55]). The experimentally observed approximate 
values of 95 ± 5 and 40 ± 5 pmol/min mg prot. at ΔΨ equal to 180 and 160 mV, 
respectively, in the presence of glutamate + malate (Fig.1 in [55]) are close to computer 
simulated values of 0.4 and 0.15 µM/s corresponding to 88 and 33 pmol/min mg prot., 
respectively, at ΔΨ equal to 180 and 160 mV in NADH-supported superoxide production in 
Fig. 3D (note that a ROS production rate of 1 µM/s equals 220 pmol/min/ mg prot). These 
computer simulated results are also quantitatively close to experimental data on the total 
ROS production rate in liver mitochondria using different respiratory substrates in the 
presence and absence of rotenone [58, 59]. For example, the succinate supported ROS 
production rate in isolated liver mitochondria is about of 200 pmol/min mg prot with 
succinate alone and 3 pmol/min mg prot in the presence of rotenone [58], which is close to 
the computer simulated approximate values of 0.9 and 0.02 µM/s in the presence of 
succinate alone and succinate + rotenone (Fig. 3D), which corresponds to 198 and 4.4 
pmol/min mg prot. Moreover, Figs. 3D and 3A show that the ROS production rate by 
Complex I during NADH oxidation becomes independent of ΔΨ in the presence of rotenone, 
compatible with experimental observations that uncoupler doesn’t affect ROS generation in 
the presence of rotenone [40, 41]. This result reflects the fact that the ΔΨ-dependent step 
(reaction (13)) of electron transfer in Complex I is inhibited by rotenone. In our computer 
simulations we had to take into account a second site of superoxide production in Complex 
I, namely the ubisemiquinone radical (complex CI.Q·− in Fig. 1), which generates 
during reverse electron transport at very high membrane potential (Fig. 3B). This 
observation is compatible with experimental data on ROS production in mitochondria from 
skeletal muscle during oxidation of succinate [7]. Elimination of this site for consideration 
of ROS formation would result in neglecting the ROS generation rate in the presence of 
succinate alone, as presented in Fig. 3A (only the FMNH− site would participate in 
superoxide formation in this case), which contradicts experimental observations [7].
Fig. 3E and F present the dependence of the respiration rate on ΔΨ and the relationship 
between the rates of respiration and total ROS production by the entire respiratory chain 
when using different respiratory substrates. The maximal respiration rate during NADH + 
succinate oxidation is approximately equal to the sum of the maximal respiration rates for 
oxidation of NADH alone and succinate alone, at least at low membrane potentials (Fig. 
3E), whereas the total ROS production rate is maximal during oxidation of succinate alone 
(Fig. 3D). These results show that the ratio of the rates of respiration and ROS production 
are highly dependent on ΔΨ as well as on the nature of the respiratory substrates (Fig. 3F) 
and can vary over a range of 0.1–1 % at the parameter values used in our base model (Tables 
1 and 2). These values are close to experimental data obtained with liver [58] or brain [53] 
mitochondria using different respiratory substrates, although they differ somewhat from the 
values of 1–2 % widely cited in the literature [60, 61]. Possible important reasons for the 
different values of the ratio of the rates of respiration and ROS production were reviewed by 
Murphy [62], who pointed out several factors which make extrapolation of ROS production 
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by isolated mitochondria to the in vivo situation invalid. The most important of these is that 
maximal ROS production occurs during RET, i.e. during oxidation of succinate alone. 
However, when glutamate/malate was used as physiological substrates H2O2 production was 
approximately 0.12% [53] of respiration. In addition, it should be pointed out that recent 
experimental and computational modeling studies [63] show that the net emission of 
hydrogen peroxide (H2O2) from mitochondria as well as the experimentally observed ratio 
of the rates of ROS production and respiration can strongly depend on the activity of 
glutathione/thioredoxin scavenging systems.
These computer simulated results were obtained in the model corresponding to the kinetic 
scheme presented in Fig. 1. It should be pointed out that different hypotheses on the 
movement of ISPH in complex III (early and late dissociation of ISPH from the Qo site as 
presented in Figs 1 and 2A) give results that are quantitatively very similar when using the 
same parameter values in the models.
Absolute values of the rates of ROS production by the mitochondrial ETC in different 
experimental studies are highly variable in different tissues and in the same tissues under 
different conditions (for review [2]). This applies to studies in forward and reverse electron 
transport as well as with and without different inhibitors of ETC. For instance, maximal 
values of the ROS production rate may vary from 130 pmol/min mg protein in human cortex 
mitochondria up to 2650 pmol/min mg protein in mitochondria from rat skeletal muscle 
when succinate alone was used as respiratory substrate and from 3 pmol/min mg prot. in rat 
liver mitochondria up to 174 pmol/min mg prot. in mitochondria from rat brain in the 
presence of succinate + rotenone (all data reproduced from Table 1 in [2]). Therefore, the 
main goal of this paper was primarily to present an analysis of possible qualitative features 
of ROS production with the different kinetic models presented in Figs. 1 and 2, rather than a 
quantitative description of ROS generation in a concrete experimental context. Relative 
changes in the rates of ROS production under variable conditions (different respiratory 
substrates and inhibitors of ETC) in the same experiments were more important for this 
study. Nevertheless, the values of kinetic parameters of superoxide production by different 
sites in our models were chosen such that the computer simulated rates of superoxide 
generation were close to those observed in liver mitochondria [58] [59].
ΔpH dependency—As pointed out by Lambert and Brand [57] the ROS production rate 
should depend equally on ΔpH and ΔΨ. However, their experimental studies unexpectedly 
show a much stronger sensitivity of ROS generation rate by Complex I to ΔpH than to ΔΨ in 
the presence of succinate alone [57]. Importantly, this feature is also observed in our 
computational model (Fig. 4A). The computational modeling analysis accounts for this 
phenomenon by the much stronger inhibition of the rate of electron transfer in Complex III 
with an increase in ΔpH than in ΔΨ. This is due to inhibition of the rate-limiting step of QH2 
oxidation in Complex III (reaction (23)) resulting from dissociation of H+ into the 
intermembrane space in reaction (23). This results in a much slower rate of QH2 oxidation in 
Complex III and a greater increase in QH2n concentration with increasing ΔpH than ΔΨ 
(Fig. 4B). As a result, the excess of QH2n forces additional reverse electron transfer in 
Complex I and increases the ROS production rate in this Complex. Computer simulation 
Markevich and Hoek Page 10
Biochim Biophys Acta. Author manuscript; available in PMC 2016 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
shows (Fig. 4C) that this effect was attenuated when the analysis was carried out on the 
assumption that reaction (23) is independent of ΔpH and ΔΨ.
However, some experimental observations [58] show no difference in ΔpH and ΔΨ 
sensitivity of the ROS generation rate. Our computer simulation analysis accounts for these 
different experimental observations by the relationship of the rate limiting steps in the Qo 
and Qi site reactions of the Q-cycle. In other words, this depends on which of these sites, the 
Qi or Qo site, limits the rate of electron transfer in the Q-cycle. A 3-fold decrease (from 900 
to 300 s−1) in the rate constant of dissociation of QH2 from the Qi site (reaction (36)) makes 
this step limiting in the Q-cycle and results in equal sensitivity of the ROS production rate to 
ΔpH and ΔΨ (Fig. 4D). Therefore, by inhibiting the Qo or Qi site we can control a difference 
in ΔpH and ΔΨ sensitivity of the ROS production rate. In summary, our computational 
model faithfully and quantitatively accounts for the characteristic features of ΔpH and ΔΨ 
dependence of ROS formation at different sites in the electron transport chain and provides a 
mechanistic underpinning for these observations.
3.2. Effects of inhibition of different segments of the respiratory chain on the ROS 
production rate
The ability of rotenone to increase ROS production by Complex I by inhibiting Q binding to 
complex I has been extensively studied experimentally (for review see [6]). Computer 
simulation results on stimulation of ROS production in the presence of rotenone (Fig. 3D) 
are quantitatively compatible both with published experimental observations that show a 3–
10-fold increase in ROS generation by rotenone during oxidation of NADH-linked 
respiratory substrates [6] and computer simulated results for cardiac mitochondria [23]. In 
order to simulate the effect of rotenone, we suggested that v8 = v14 = 0 in the computational 
model. Such a high stimulation of ROS production by rotenone is observed in our model in 
the range of membrane potential below approximately 160 mV during oxidation of NADH 
alone and with NADH+succinate (Fig. 3D).
In further analyses, in order to discriminate between computational models that derive from 
kinetic schemes with different mechanisms of QH2 oxidation in the Qo site presented in 
Figures 1 and 2 (with early and late ISPH dissociation and involving oxidized quinone 
dissociation from reduced cyt bL) the effects of different inhibitors of Complexes III and IV 
on ROS production were simulated.
3.2.1. Inhibition of the Qi site—Antimycin A (AA) is the most widely used inhibitor of 
the Qi site of complex III in experimental [64] and computational [23] studies of ROS 
generation in the respiratory chain because of its ability to enhance ROS production. AA 
binding to the Qi site near cyt bH inhibits electron transfer from cyt bH to ubiquinone at the 
Qi site. However, the exact mechanism of this inhibition is not clear, because a widely 
accepted hypothesis about competition between AA and Q for binding to the Qi site 
contradicts some experimental observations [65]. In order to simulate computationally the 
inhibitory effect of AA on the Qi site we applied the minimal hypothesis that AA inhibits 
completely the rate of electron transfer from cyt bL to bH at the Qi site (reaction (34)), i.e. 
v34 = 0 in the presence of AA. It should be noted that v34=0 intrinsically results in 
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suppressing the reactions of electron transport from the semiquinone to cyt bL and from cyt 
bL to cyt bH at the Qo site, i.e. v24 = 0 and v25 = 0 at steady state for the following reasons. 
First, inhibition of reaction (34) results in inhibition of all reactions of electron transfer at 
the Qi site at steady state, i.e. v32 = v33 = v34 = v35 = v36 = 0. Second, inhibition of the Qi 
site results in suppressing the reactions of electron transfer at the Qo site at steady state due 
to a break in the Q cycle. Because the concentration of reduced cyt bH, [bH−], and the 
complex of reduced cyt bL with oxidized Q, [bL−.Q], (see Fig. 1) are governed by 
differential equations d[bH−]/dt = v25 – v32 and d[bL−.Q]/dt = 2 · v24 – v25 – v34 which equal 
0 at steady state, therefore, v25 = v32 = 0 and v24 = v25 = v34 = 0 at steady state, i.e. v24 = 0 
and v25 = 0. It should be noted that all these arguments are valid also for the model with late 
ISPH dissociation (Fig. 2A). (For detail see the mathematical models corresponding to 
different kinetic schemes in Supplementary data). A detailed analysis of the branched model 
in which oxidized Q can leave or bind to the Qo site when cyt bL is reduced will be 
presented below in the section 3.2.5. The Q-dependence of ROS production by antimycin-
inhibited Complex III.
Fig. 5 presents the computer simulated superoxide production rate by complexes I and III 
with succinate as respiratory substrate in the absence or presence of AA, for different 
computational models deriving from kinetic schemes presented in Figs 1 and 2A.
These computer simulation results predict that models with early (model E) and late (model 
L) ISPH dissociation will show different quantitative and qualitative responses in ROS 
production upon application of AA. Model L predicts (Fig. 5B, D) a very large increase in 
the rate of ROS production in the presence of AA with decreasing membrane potential, 
which is compatible with the experimentally observed [64] strong stimulation of H2O2 
production in antimycin-supplemented rat and pigeon heart mitochondria by the addition of 
protonophores and ionophores. By contrast, model E (Fig. 5A, C) shows a non-monotonic 
profile and a decrease in AA-stimulated ROS formation at low membrane potential. These 
different computer simulated AA-induced ROS responses at low membrane potential in 
models E and L are accounted for as follows. The activity of cytochrome c oxidase 
(Complex IV) is very high at low membrane potential. Therefore, all electron carriers 
located downstream of the reaction blocked by AA, i.e., ISP, cyt c1 and cyt c, become 
completely oxidized. The extremely low ISPH concentration at low membrane potential 
shifts the equilibrium of reaction (24) to complex bL−.Q in model E (see for detail 
Supplementary Fig. S1). Therefore, the concentration of the  producing site complex bL. 
Q·−.ISPH and the rate of ROS production by Complex III become negligible at low 
membrane potential in model E (Fig. 5A, C). By contrast, the concentration of the complex 
bL.Q·−.ISPH in model L does not depend directly on the concentration of ISPH. Therefore, a 
large decrease in the ISPH concentration upon depolarization of the mitochondrial 
membrane in the presence of AA should not strongly affect ROS production in model L. In 
order to clarify the mechanism of a large increase in ROS production by AA-inhibited 
Complex III observed in model L upon computer simulated depolarization (Fig. 5B, D), an 
analysis of ΔΨ-dependent reaction (23) in model L was carried out.
Our computational analysis shows that in model L an increase in ROS production by AA-
inhibited Complex III upon depolarization occurs due to ΔΨ-dependent release of the first 
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H+ of QH2 into the intermembrane space (IMS) in the reaction (23) at the Qo site (Fig. 2A). 
Depolarization facilitates the release of H+ into the IMS and shifts the equilibrium in this 
reaction toward formation of the unstable semiquinone, the complex bLQ·−.ISPH. The 
efficacy of ΔΨ-dependent H+ release depends on how readily H+ diffuses through the 
membrane to the IMS after its release from the Qo site and is characterized by the 
dimensionless parameter δ1. If δ1 = 0 no increase is observed in the concentration of the 
unstable semiquinone in Complex III and the rate of ROS production by Complex III 
(Supplementary Fig. S2A and S2B) upon depolarization of the inner mitochondrial 
membrane. By contrast, the higher δ1, the more steeply ROS production increases upon 
depolarization (Fig.S2A and S2B). Experimental observations show that H2O2 production in 
AA-inhibited mitochondria can be stimulated as much as 13-fold by the addition of 
protonophores [64]. The steepness of the ΔΨ-dependency of ROS production in the presence 
of AA suggests the conclusion that δ1 may be considerable and will have to be taken into 
account in the modeling study. The suggestion that the second proton has to travel a 
considerable distance (after the first proton passes to ISPox) to go from the protonated 
semiquinone to the IMS aqueous phase is supported by molecular dynamics simulations and 
crystallographic studies of Complex III reviewed in [8]. These studies show that protonated 
semiquinone passes a proton to Glu-272 of cyt b, the side chain of which rotates so that the 
carboxylic acid group contacts a water chain leading to the IMS aqueous phase [8]. Thus, 
the second proton does appear to travel a large distance to reach the IMS aqueous phase 
after it leaves the semiquinone bound to the Qo site. We have used δ1 = 0.2 in our 
computational model.
It should be pointed out that our computations predict a decrease in the total ROS production 
rate in the presence of AA compared to the uninhibited condition at ΔΨ > 145 mV during 
oxidation of succinate alone in both models (Fig. 5A,B), even though an increase in the rate 
of  generation by the unstable semiquinone of the Qo site of Complex III is observed 
over the entire range of membrane potential (Fig. 5C,D). The antimycin-induced decrease in 
the total rate of ROS production at ΔΨ>145 mV results from a strong decrease in the rate of 
 generation by the semiquinone of Complex I upon inhibition of Complex III (data not 
shown). This effect will be considered in more detail below with inhibition of the Qo site of 
Complex III (Fig. 7C). In addition, our computations predict an increase in the total ROS 
production rate over the entire range of ΔΨ upon inhibition of the Qi site by AA during 
oxidation of NADH+succinate in both, E and L, models (Supplementary Fig.S2A and S2B). 
This occurs due to the strong increase in the rate of  formation by FMNH− of Complex I 
upon inhibition of Complex III (Fig. 7B).
Of special interest is the ROS production rate upon partial inhibition of the Qi site by AA. 
Experimental studies show that the dependence of the rate of electron transport in uncoupled 
submitochondrial particles [66] and isolated bc1 complexes [67] on the concentration of AA 
is sigmoid rather than linear. This means that a low concentration of AA has little inhibitory 
effect on the activity of electron transport at low membrane potential. Moreover, recent 
experimental [68] and theoretical [69] studies show that a low concentration of AA can 
stimulate the activity of isolated dimeric bc1 complexes due to inter-monomeric electron 
transport between cytochrome b subunits. In the current study, we don’t consider the 
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concentration dependency of AA, but analyze computationally the effect of AA-induced 
alterations in the rate of electron transfer from cyt bL to bH at the Qi site, i.e. the rate 
constant k34, on the rates of respiration and ROS production. In order to take into account 
possible alterations in membrane potential upon a partial inhibition of the Qi site we 
analyzed changes in k34 at different ΔΨ.
Fig. 6 presents the analysis of the effect of a decrease in k34 on the rates of respiration (Fig. 
6A) and ROS production (Fig. 6B–E) by different sites of the electron transport chain at 
different membrane potential values. As shown in Fig. 6A, the respiratory rate has a 
sigmoidal dependency on k34 and decreases very slowly when k34 decreases from 105 to 10–
100 s−1 at different ΔΨ. This implies that reaction (34) limits the rate of electron transfer in 
the Q-cycle at values of k34 < 100 s−1. The same sigmoidal k34-dependence is observed in 
the total rate of ROS generation by both Complexes I and III (Fig. 6B) and in the rates of 
ROS formation by the reduced flavin of Complex I (Fig. 6C), the unstable semiquinone of 
Complex III (Fig. 6D) and the semiquinone of Complex I (Fig. 6E). The rates of ROS 
production by different sites also slightly depend on k34 over the range above 10–100 s−1, 
i.e. in a range of k34 where there is only a modest inhibition of the Qi site by AA. A 
transition of the respiratory rate from high to low levels when the Qi site is strongly 
inhibited by AA, (i.e. when k34 decreases below 10–100 s−1), is accompanied by a transition 
to a high total rate of ROS production. The ΔΨ dependency of ROS production at different 
sites also differs when AA inhibition of the Qi site is modest or strong. The effects of 
alterations in AA inhibition (reflected in k34) and ΔΨ on ROS formation at the reduced 
flavin of Complex I are presented in Fig. 6C. Both factors, a decrease in k34 and an increase 
in ΔΨ, reduce electron carriers of Complex I and thereby stimulate ROS production by the 
reduced flavin. The effect of either of these is most effective in the absence of the other 
factor. Hyperpolarization of the inner mitochondrial membrane strongly stimulates ROS 
production by FMNH− when the Qi site of Complex III is only weakly inhibited by AA (i.e. 
at high k34), but does not affect ROS formation when AA -induced inhibition of Complex III 
is almost complete. By contrast, the rate of ROS generation by AA-inhibited Complex III at 
k34 < 10 s−1 is stimulated very strongly by depolarization of the inner mitochondrial 
membrane (Fig. 6D) as discussed above. However, a decrease in ΔΨ inhibits ROS 
production by the unstable semiquinone when Complex III is only moderately inhibited by 
AA. As shown above (Fig. 3B) the rate of ROS production by the semiquinone of Complex 
I is negligible at ΔΨ < 140 mV in the absence of AA. Fig. 6E confirms this result and shows 
negligible ROS production at the CI.Q·− site at ΔΨ < 140 mV with both partial and complete 
inhibition of Complex III by AA. However, the semiquinone of Complex I forms  at a 
considerable rate at very high values of membrane potential (ΔΨ = 180 mV) and this rate is 
almost independent of inhibition of Complex III by AA, confirming that it is a direct effect 
of ΔΨ on the four protons extruded through Complex I. Fig. 6F shows computer simulated 
relationships between the rates of respiration and overall ROS production by both 
Complexes I and III upon partial inhibition of the Qi site by AA at different ΔΨ. All curves 
represent data shown in Fig. 6A and 6B. An important feature of these relationships is the 
existence of a plateau in the dependence of ROS production on the respiratory rate. This 
means that the rate of ROS production by the AA-inhibited respiratory chain has a weak 
sensitivity to the rate of respiration and remains almost constant before the respiratory rate 
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reaches saturation. This feature differentiates ROS production in the electron transport chain 
without any inhibitors (see for comparison Fig. 3F) and upon partial inhibition by AA. This 
difference is accounted for by the fact that the main source of ROS is different in the 
presence and absence of AA. The main source of ROS in the AA-inhibited electron transport 
chain is Complex III (Fig. 6D) while sites of Complex I prevail in ROS formation in the 
absence of the inhibitor.
3.2.2. Inhibition of the Qo site—Stigmatellin and myxothiazol are well known 
inhibitors of the Qo site of Complex III which have different effects on the ROS production 
rate [55, 70–72]. X-ray crystallographic studies of complex III [44, 73] show that these 
inhibitors occupy the quinol binding pocket of the Qo site, so, they may compete with quinol 
for binding to the Qo site [12]. On the other hand, stigmatellin and myxothiazol bind to 
different domains of the quinol binding pocket (for reviews see [11, 12, 74]). Stigmatellin 
binds to the distal domain near the 2Fe2S cluster of ISP, so, stigmatellin fixes the extrinsic 
domain of ISP (ISP-ED) in the cythocrome b position while myxothiazol occupies the 
proximal domain close to the bL heme and doesn’t result in a fixed ISP-ED positioning [75].
Despite these achievements in understanding the structure-function relationships in Complex 
III, there is no a consensus on the exact steps of QH2 oxidation in the Qo site that are 
inhibited by stigmatellin and myxothiazol. Differential effects of stigmatellin and 
myxothiazol on ROS production by Complex III could help clarify this situation. 
Experimental observations show [70] that isolated bc1 complexes generate  in the 
presence of myxothiazol, while stigmatellin completely prevents ROS production by the bc1 
complex. Moreover, myxothiazol stimulates ROS production in mitochondria, although less 
so than AA [70]. In order to clarify the underlying steps, we modeled the rate of ROS 
production in the respiratory chain with models E and L using a simulated response to 
inhibition of the first and second electron transfer in the Qo site. We assume the rate of 
reactions (23) and (24) to equal 0 in the presence of succinate as respiratory substrate (Fig. 
7). It should be noted that models E and L show the same results for simulated ROS 
production rates when v23=0 and v24=0. Therefore, Fig. 7 presents results only for model E.
Inhibition of the first electron transfer in the Qo site (v23=0): Fig.7 shows that inhibition 
of the first electron transfer (v23=0) results in a large decrease in total ROS production rate 
(Fig. 7A) due to a strong inhibition of superoxide anion generation by the semiquinone of 
Complex I (Fig. 7C) and elimination of  formation by the unstable semiquinone of the 
Qo site of Complex III (Fig. 7D). A large increase in the rate of  formation by FMNH− 
of Complex I (Fig. 7B) when v23=0 cannot compensate for the overall decrease in the ROS 
production rate. These computer simulated results are compatible with the experimentally 
observed effect of stigmatellin on the ROS production rate both in cytochrome bc1 
complexes isolated from bovine heart and yeast [55, 71, 72] and in rat heart and brain 
mitochondria [70].
Inhibition of the second electron transfer in the Qo site (v24=0): Computer simulated 
results of the ROS production rate upon inhibition of the second electron transfer in the Qo 
site (v24=0) are also presented in Fig. 7. These results show that the ROS production rate 
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when v24=0 is identical to the rate obtained under conditions that simulate the AA presence 
(v34 = 0) in model L (Fig. 5B, D). The total ROS production rate under these conditions is 
very high (much higher than in the uninhibited control) over the entire range of membrane 
potential below a ΔΨ of approximately 145 mV (Fig. 7A). This high total ROS production 
rate is accounted for by a very strong increase in the rate of  formation by the unstable 
semiquinone of Complex III (Fig. 7D). A decrease in the total ROS production rate 
compared to the control at ΔΨ > 145 mV occurs due to a strong decrease in the rate of 
formation by semiquinone of Complex I (Fig. 7C). These computer simulated results are 
compatible with experimental observations that myxothiazol stimulates ROS production in 
brain [70] and liver [71] mitochondria although less so than AA. This observation can be 
accounted for as follows. Myxothiazol partly inhibits the first electron transfer due to its 
competitive inhibition of QH2 binding to the Qo site. This results simultaneously in an 
activating (due to inhibition of the second electron transfer) and an inhibitory action on ROS 
production by Complex III (because of partial inhibition of the first electron transfer). Our 
computational data presented in Supplementary Fig. S3 confirm the hypothesis that 
simultaneous complete inhibition of the second electron transfer and partial inhibition of 
QH2 binding to the Qo site by myxothiazol can account for the experimentally observed 
stimulation of ROS production, which is weaker than that obtained by AA [70].
It should be noted that the total ROS production rate increases over the entire range of ΔΨ 
upon inhibition of the second electron transfer in the Qo site during oxidation of NADH 
alone or NADH + succinate (Supplementary Fig. S4).
3.2.3. Inhibition of cytochrome c oxidase—Based on experimental observations of 
oxidative cellular injury during ischemia and reperfusion, which decreases cytochrome 
oxidase activity, some authors [76–78] proposed that inhibition of cytochrome c oxidase 
may facilitate ROS production by the respiratory chain. However, a direct experimental 
measure of ROS production in intact rat heart mitochondria and corresponding 
submitochondrial particles (SMP) [77] showed that an increase in ROS production upon 
inhibition of cytochrome c oxidase by azide was observed only in SMP oxidizing NADH.
In order to understand what changes in ROS production rates occur at different sites of the 
respiratory chain upon inhibition of cytochrome c oxidase, we used the computational 
modeling analysis, simulating inhibition of cytochrome c oxidase by assuming that the rate 
v40 = 0 in models E and L.
The computer simulated ROS production rate in model L with complete inhibition of 
cytochrome c oxidase (i.e., v40 = 0) with NADH as a respiratory substrate, is presented in 
Fig. 8. Fig. 8A shows that the simulated total ROS production by Complexes I and III 
significantly increases upon inhibition of cytochrome c oxidase compared to the uninhibited 
control at low membrane potential (ΔΨ < 120 mV), whereas practically no changes in ROS 
production occur at ΔΨ > 120 mV. This increased level in total ROS production is 
completely accounted for by a very strong increase in the rate of  formation in Complex 
I at the FMNH− site, over the entire range of membrane potential (Fig. 8B). In this case, 
inhibition of cytochrome c oxidase results in identical changes in ROS production by 
Complex I as when Complex I is inhibited by rotenone (see Fig. 3A). A modest decrease in 
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the simulated rate of  formation by the semiquinone of Complex I as well as by the 
unstable semiquinone of Complex III at ΔΨ < 120 mV is observed when v40 = 0 (Fig. 8C, 
D). However, ROS production by the unstable semiquinone of Complex III decreases 
considerably at ΔΨ > 120 mV.
It should be pointed out that curves related to NADH-induced superoxide production 
presented in Fig. 8 as well as above in Fig. 3 and below in Fig. 10 exhibit a notable dip, 
which indicate the possible existence of bistability (two alternative stable states in the rates 
of respiration and ROS production under otherwise identical conditions) in the operation of 
the respiratory chain. The phenomenon of bistability in ROS production by the 
mitochondrial electron transport chain was first observed experimentally by Selivanov and 
colleagues and accounted for with the help of their rule-based model [19, 20]. Bistability of 
Complex III was recently confirmed computationally in the six-state model with the native 
parameters [24]. A detailed analysis of this phenomenon in the entire respiratory chain was 
carried out by us with the help of an earlier version of our computational model and recently 
published elsewhere [27]. It was shown [19, 20] that during oxidation of any respiratory 
substrates, succinate or/and NADH-linked substrates, hysteresis and bistability in the entire 
respiratory chain can arise owing to the specific features of the Q-cycle in Complex III, in 
which the Qo and Qi site compete for the substrate ubiquinone reflecting total 
intramembrane ubiquinone conservation (for detail see [19, 20, 27]). The physiological 
implications of a possibility that the respiratory chain can exist in two alternative stable 
states with different rates of ROS generation is discussed in these earlier publications [19, 
20, 27]. In particular, it was suggested [19, 20] that this phenomenon may be critical to 
account for the oxidative stress resulting from anoxia/re-oxygenation (ischemia/reperfusion). 
A detailed analysis of hysteresis and bistability in the respiratory chain is beyond the scope 
of this paper, therefore, we do not devote further attention to this phenomenon here.
Interestingly, in contrast to NADH oxidation, using succinate as a substrate for the 
respiratory chain results in the opposite results (Fig. 9), i.e., all computer simulated rates of 
ROS production decrease upon inhibition of cytochrome c oxidase (v40 = 0) compared to the 
condition without the inhibitor, including the total ROS production rate (Fig. 9A), the rate of 
 formation by the semiquinone of Complex I (Fig. 9C) and by the unstable semiquinone 
of Complex III (Fig. 9D). Only the simulated rate of ROS generation by reduced FMNH− of 
Complex I is considerably increased at v40 = 0 in the presence of succinate (Fig. 9B). 
However, this increase does not compensate for the decrease in ROS production at the other 
two sites of  formation. It should be noted that a decrease in the rate of ROS production 
by Complex III upon inhibition of cytochrome c oxidase by cyanide was observed in recent 
computational studies [23].
The strong decrease in the rate of ROS generation by the semiquinone of Complex I upon 
inhibition of cytochrome c oxidase during oxidation of succinate alone (Fig. 9C) deserves 
special attention. This additional site of ROS generation in Complex I is usually attributed to 
excessive ROS production during reverse electron transfer (RET). Therefore, at first glance, 
inhibition of cytochrome c oxidase should result in an increase in ROS generation at this 
site. However, this is not observed. The semiquinone concentration is held in equilibrium 
with both Q and QH2. Upon inhibition of cytochrome c oxidase during oxidation of 
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succinate the concentration of oxidized Q approaches zero, because there is no respiration 
and no oxidation of QH2 by Complex III. This results in a strong decrease in the 
concentration of the semiquinone in Complex I. In this case, almost all superoxide in 
Complex I is generated by reduced FMNH− (Fig. 9B). This result may account for recent 
experimental observations [79] that NADH and succinate, upon inhibition of cytochrome c 
oxidase by KCN, both induced ROS production by the same site, FMNH−.
3.2.4. Depletion of cytochrome c
Experimental observations show that loss of cyt c from mitochondria results in a 
considerable increase in the ROS production rate with NADH-linked substrates [52, 80], 
whereas ROS decreases with succinate as electron donor [81]. We analyzed computationally 
the effects of cyt c depletion from the mitochondrial intermembrane space (IMS) on the 
ROS production rate by different sites of Complexes I and III during oxidation NADH alone 
and succinate alone. Fig. 10 presents the computer simulated ΔΨ dependency of the total 
ROS production rate (Fig. 10A) and ROS production at different sites of Complex I (Fig.
10B, C) and Complex III (Fig. 10D) with different cyt c concentrations, [Cyt c], in the IMS 
during the oxidation of NADH alone. The overall rate of ROS production (Fig. 10A) 
significantly increases upon extensive (more than 90%) depletion of cyt c at low membrane 
potential (ΔΨ < 120 mV), whereas practically no changes in ROS production occur at ΔΨ > 
120 mV. It should be noted that the respiration rate becomes saturated at ΔΨ = 120 mV 
during oxidation of NADH alone (Fig. 3E). The considerable increase in the total ROS 
production rate upon complete cyt c depletion ([Cyt c]=0) results from a strong increase in 
 formation by reduced FMNH− of Complex I (Fig. 10B). An increase in the ROS 
production rate at 0 < [Cyt c] < 70 µM and at ΔΨ < 120 mV occurs due to an increase in 
formation by the semiquinone of the Qo site (Fig.10D). Practically no changes in the ROS 
production rate occur at the semiquinone of Complex I (Fig. 10C) upon cyt c depletion.
By analogy, Fig. 11A–D presents the computer simulated rates of ROS production at 
different sites of the respiratory chain with different [Cyt c] during oxidation of succinate 
alone. In this case, the ROS production rate by the semiquinone of Complex I (Fig. 11C) 
decreases considerably with a decrease in [Cyt c], which results in a decrease in the total 
ROS production rate at ΔΨ > 140 mV (Fig. 11A). However, an increase in the total ROS 
production rate during oxidation of succinate alone occurs with cyt c depletion at ΔΨ < 140 
mV due to an increase in  formation by the unstable semiquinone of the Qo site of 
Complex III (Fig. 11D). It should be noted that the respiration rate becomes saturated at ΔΨ 
= 140 mV during oxidation of succinate alone (Fig. 3F). The rate of ROS generation by 
reduced FMNH− of Complex I increased with cyt c depletion (Fig. 11B).
Thus, the computer simulated responses to cyt c depletion are similar to those obtained upon 
inhibition of cytochrome c oxidase. This similarity is expected because inhibition of 
cytochrome c oxidase and cyt c depletion results in a similar reduction of electron carriers 
upstream of cyt c. The computational results presented are in agreement with experimental 
observations of the opposite effect of cyt c depletion on ROS production during NADH [52, 
80] and succinate oxidation [81]. It is important to note that a decrease in ROS production 
with succinate alone probably occurs due to a decrease in ROS production by the 
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semiquinone of Complex I (Fig. 11C). An additional feature of cyt c depletion is the 
decrease in the rate of oxidation of superoxide anion to oxygen by cyt c, i.e. a decrease in 
scavenging of superoxide. However, an increase in the superoxide concentration that results 
from a scavenging decrease does not affect the rate of superoxide generation due to the low 
reversibility of this reaction.
3.2.5. The Q-dependence of  production by antimycin-inhibited Complex III
Our previous analysis of computational models E and L was related mainly to steady state 
dependencies of the rates of respiration and  production on membrane potential. 
However, recent experimental observations of unexpected non-monotonic dependencies of 
ROS production by Complex III in the presence of antimycin A (AA) on the activity of 
succinate dehydrogenase [17, 18] and the concentration of the oxidized ubiquinone Q [18] 
suggest it is important to pay more attention to the Q-dependence of  production. 
Following Crofts and colleagues [12], we suggested in our current models that QH2 and Q 
bind to the Qo site with oxidized cyt bL only, i.e. we excluded the branch of QH2 oxidation 
at the Qo site in which cyt bL is reduced. This suggestion is supported in part by the work 
[17] published recently by Brand and coworkers. These authors showed that QH2 oxidation 
by the branch in which QH2 binds to the Qo site at reduced cyt bL should occur with a very 
slow rate in order to account for their experimental data [17]. However, binding of Q to the 
Qo site at reduced cyt bL has to be taken into consideration in order to account for some 
experimental data on ROS production by AA-inhibited Complex III, especially, the non-
monotonic dependencies of ROS production on the concentration of respiratory substrates 
and oxidized Q. Previous experimental observations [17, 18, 82] showed that ROS 
production by AA-inhibited Complex III in the presence of a high concentration of succinate 
was enhanced by malonate, a competitive inhibitor of succinate dehydrogenase. Moreover, 
ROS production by AA-inhibited Complex III showed a non-monotonic dependence on the 
concentration of different respiratory substrates for Complexes I and III and the redox states 
of cyt bL [17] and ubiquinone Q pool [18]. An initial increase in ROS production by 
antimycin-inhibited Complex III with increasing concentrations of different respiratory 
substrates and ubiquinol QH2, respectively, can be understood intuitively because addition 
of respiratory substrates supplies electrons to the redox centers of Complex III, including the 
ROS producing unstable semiquinone. Therefore, the concentration of unstable semiquinone 
should increase with increasing concentrations of these substrates. However, a further 
unexpected decrease in ROS production at a high concentration of respiratory substrates, i.e. 
with a high QH2/Q ratio, is harder to explain in the framework of the generally accepted 
concept that ubisemiquinone is formed during ubiquinol oxidation only. Therefore, in order 
to account for a decrease in ROS production by antimycin-inhibited Complex III with 
increasing QH2/Q ratio (and an increase in ROS production with increasing oxidized 
ubiquinone Q) Drose and Brandt [18] proposed that oxidized ubiquinone supports 
ubisemiquinone formation and, respectively, superoxide production at the Qo site due to 
transfer of electrons from reduced cyt bL onto Q in a reverse reaction of the Qo site. In 
models E and L, this is the reverse direction of reaction (24) presented in Fig. 1 and Fig. 2A. 
This implies that, in order to force this reverse reaction of electron transfer from reduced cyt 
bL onto Q and increase superoxide production, free oxidized coenzyme Q has to support 
formation of the complex of Q with reduced cyt bL, i.e. complexes bL−.Q and bL−.Q.ISPH in 
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Fig. 1 and Fig. 2A, respectively, as substrates of reaction (24) taken in the reverse direction. 
In models E and L, this is impossible for the following reason. Binding of free oxidized 
coenzyme Q to the Qo site in both E and L models occurs in the reverse direction of reaction 
(26) in Fig. 1 and 2A, which is downstream of reaction (25) of electron transfer from cyt bL 
to cyt bH, i.e. when cyt bL is oxidized. This means that, in order to increase the 
concentration of free oxidized ubiquinone Q would result in increasing the concentration of 
complexes bL−.Q and bL−.Q.ISPH, respectively, in Fig. 1 and Fig. 2A, electron transfer from 
cyt bH to cyt bL in the reverse direction of reaction (25) should occur. However, we 
suggested earlier in Section 3.2.1 that reaction (25) is depressed in both forward and reverse 
directions in the presence of AA. This means that in models E and L, an increase in the free 
oxidized ubiquinone Q concentration cannot result in an increase in the ubisemiquinone 
formation and ROS production by AA-inhibited Complex III due to the reversal of reaction 
(24). Therefore, we extended model L and suggest that the free oxidized ubiquinone Q can 
bind to the Qo site when cyt bL is reduced. In other words, we considered a new branched 
model in which coenzyme Q can bind/leave the Qo site before electron transfer from bL to 
bH occurs (the reversible reaction (41) presented in the modified kinetic scheme in Fig. 2B). 
The branched kinetic scheme of the Q-cycle presented in Fig. 2B takes into account the 
consecutive release of Q and ISPH from the Qo site and differs from the kinetic scheme 
presented in Fig. 2A by additional reactions (41), (42), (25a) and (34a). A mathematical 
model corresponding to this branched kinetic scheme (Fig. 2B) is presented in 
Supplementary data. Some of the steady state characteristics of this mathematical model 
based on the assumption that v34=v34a=0 in the presence of AA are presented in Fig. 12. Fig. 
12A shows that the modified branched model describes qualitatively the experimentally 
observed non-monotonic dependence of ROS production on the activity of succinate 
dehydrogenase (Complex II) [17, 18] simulated in the model as changes in the maximal rate 
of Complex II, Vmax19 (see reaction (19) in Table 1). The mechanism responsible for the 
bell-shaped dependence of the rate of ROS production can be understood from the data 
shown in Fig. 12B, which presents the relationship between the maximal rate of Complex II, 
the fractions of oxidized ubiquinone Q and reduced cyt bL, and the concentration of complex 
bL−.Q.ISPH, i.e., the substrate for the formation of semiquinone at the Qo site in the reverse 
direction of reaction (24). The ternary complex bL−.Q.ISPH is a product of three 
simultaneous events, namely, Rieske iron-sulfur protein ISP and cyt bL have to be in the 
reduced form and ubiquinone Q in the oxidized state. Let us consider only changes in the 
steady state fractions of the reduced cyt bL and oxidized ubiquinone Q, as the donor-
acceptor pair in this complex, when the maximal rate of Complex II changes. Fig. 12B 
shows that the fraction of reduced cyt bL and oxidized ubiquinone Q changes reciprocally 
with changes in the maximal rate of Complex II. This feature is the main reason for the non-
monotonic dependence of ROS production on the maximal rate of Complex II shown in Fig. 
12A. At a low rate of Complex II, when the Q pool and cyt bL are mainly in the oxidized 
state, the concentration of the complex bL−.Q.ISPH is very low due to low levels of reduced 
cyt bL (Fig. 12B). By analogy, complex bL−.Q.ISPH approaches zero at very high rates of 
Complex II due to the fraction of oxidized ubiquinone Q being negligible. Therefore, the 
steady state dependence of the concentration of the complex bL−.Q.ISPH on the maximal 
rate of Complex II is non-monotonic with a peak concentration of about 4 µM when the 
maximal rate of Complex II is around 60 µM/s, near the intersection point of the curves for 
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the reduced cyt bL and oxidized ubiquinone Q fractions (Fig. 12B). For similar reasons, the 
steady state dependence of the concentration of complex bL.QH2.ISPox on the maximal rate 
of Complex II is also non-monotonic, due to the reciprocal changes in oxidized cyt bL and 
reduced ubiquinone QH2 with changes in the maximal rate of Complex II. It should point 
out that complex bL.QH2.ISPox is the substrate for semiquinone formation during ubiquinol 
oxidation in reaction (23) (Fig. 2B). Peak values of the complex bL.QH2.ISPox 
concentration about 240 µM at the same values of the maximal rate of Complex II of 60 
µM/s as for the complex bL−.Q.ISPH (data not shown). Since the semiquinone concentration 
at the Qo site, the bL.Q·−.ISPH complex, is held in equilibrium with the both bL.QH2.ISPox 
and bL−.Q.ISPH complexes, it is easy to understand that the concentration of the 
bL.Q·−.ISPH complex and superoxide production by this complex follows the concentration 
of both the bL.QH2.ISPox and bL−.Q.ISPH complexes and changes non-monotonically with 
changes in the maximal rate of Complex II as shown in Fig. 12A. This is true especially in 
the presence of AA when the respiration rate is very low and redox centers in Complex III 
are in the quasi-stationary state close to equilibrium. In addition, computer simulation also 
shows a bell-shaped dependence of superoxide production by the AA-inhibited Complex III 
on the relative fraction of the oxidized ubiquinone Q (Fig. 12C) and reduced cyt bL (Fig. 
12D), compatible with the experimentally observed nonmonotonic dependencies of ROS 
production on the redox states of ubiquinone Q pool [18] and cyt bL [17]. However, further 
computer fitting procedure will be needed to account quantitatively for these experimentally 
observed dependencies. All computational results presented in Fig. 12 were obtained at ΔΨ 
= 0 and v34 = v34a = 0 in order to simulate the effect of AA. It should be pointed out that 
changes in the oxidized ubiquinone Q and reduced cyt bL fractions presented on the x-axis 
in Fig. 12C and 12D were obtained in the steady state of the branched model assuming 
changes in the maximal rate of Complex II. This means that changes in the steady state 
fraction of the oxidized ubiquinone Q (reduced cyt bL) are accompanied by simultaneous 
reciprocal changes in reduced cyt bL (oxidized Q), as shown in Fig. 12B, i.e. maximal 
steady state values of oxidized Q (reduced cyt bL) correspond to minimal values of reduced 
cyt bL (oxidized Q). This is the underlying reason for the non-monotonic dependence of 
ROS production in the branched model when it is plotted against the relative fraction of the 
oxidized ubiquinone Q (Fig. 12C) and reduced cyt bL (Fig. 12D).
We evaluated how these additional steps in the modified branched model affect the results 
reported above with models E and L under uninhibited conditions and, especially, upon 
inhibition of reactions downstream of Complex III. A comparison of the computational 
results from model L and the modified branched model shows that they are quantitatively 
very close, both with and without inhibition of cytochrome c oxidase (Supplemental Fig. 
S5). However, the superoxide production rate in the branched model differs quantitatively 
from the rate in model L upon inhibition of Complex III by AA (Supplemental Fig. S6). The 
qualitative features of the curves of superoxide production in the both models are similar, 
however, i.e. the superoxide production rate increases with decreasing membrane potential, 
in agreement with experimental data [64]. The decrease in superoxide production by AA-
inhibited Complex III in the branched model compared to the model L relates to a decrease 
in the concentration of the  producing site complex bL.Q·−.ISPH (Fig. 2B), reflecting the 
additional outflow of oxidized Q from the Qo site in the reaction (41). Thus, reaction (41) 
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plays an important role in the increase in  production by Complex III at partial oxidation 
of the Q pool, due to reverse electron transfer from reduced cyt bL to oxidized Q in reaction 
(24) in Fig. 2B, as was suggested earlier by different authors [18, 83].
In addition, we should point out that both the branched model and model L exclude a short 
circuit in the Q-cycle because these models are based on the experimentally supported 
hypothesis [11] that suggests that dissociation of ISPH from the Qo site occurs only after the 
second electron transfers from cyt bL to bH (reaction (26) in Figs 2A, B). In this case, the 
rate of respiration in the electron transport chain inhibited by AA closely matches the rate of 
 production by complex bL.Q·−.ISPH. This results from the suggestion that v34=0 and 
v34=v34a=0 in model L and the branched model, respectively, simulating inhibition of the Qi 
site by AA. (For further detail, see the mathematical models corresponding to different 
kinetic schemes in Supplementary data). However, some authors [83] experimentally 
observed a reduction of cyt c by the AA-inhibited cytochrome bc1 complex with a rate that 
did not depend on the rate of  production, which implies a short circuit in the Q-cycle. 
Therefore, we cannot exclude the possibility that the kinetic scheme of the favorable 
branched model presented in Fig. 2B can be extended due to additional reactions involving, 
in particular, a slow dissociation of ISPH from the Qo site before the second electron 
transfers from cyt bL to bH, i.e. slow ISPH dissociation from complexes bL−.ISPH and 
bL.Q·−.ISPH. This additional slow dissociation of reduced ISPH would be followed by its 
oxidation by cyt c1 and a return of oxidized ISPox to the Qo site, where it would accept the 
second electron from the  forming unstable semiquinone to produce the second molecule 
of reduced ISPH. This mechanism can, first, explain a possible slow short-circuit when both 
electrons transfer from QH2 into the high potential c-chain [13] and, second, develop an 
additional mechanism to control  production by Complex III.
4. Conclusions
In this paper, we have developed a computational model of superoxide formation in the 
mitochondrial electron transport chain based on a detailed kinetic scheme of the electron 
transfer reactions in Complex I and III. The model has the flexibility to account for multiple, 
often seemingly contradictory observations on the effects of ΔΨ and ΔpH, as well as for the 
effects of multiple substrate and inhibitor conditions reported on the literature. Table 3 
summarizes the ROS production rates under different substrate and inhibitor conditions and 
the contribution of the different ETC sites considered. The major important findings 
highlighted in our analyses can be summarized as follows:
The computational model accounts for experimentally observed ΔΨ dependency of the 
ROS production rate with different respiratory substrates and supports a hypothesis about 
the semiquinone of Complex I as an additional  generating site
Our computational modeling results confirm the very high ΔΨ sensitivity of the ROS 
production rate observed experimentally [57] and theoretically [23] in mitochondria using 
succinate or NADH-linked respiratory substrates [7, 55, 56] and predict also the strong ΔΨ-
dependency of ROS production for NADH + succinate oxidation (Fig. 3). Moreover, the 
computer simulation (Fig. 3A, D) shows that the ROS production rate by Complex I for 
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NADH oxidation becomes independent of ΔΨ upon rotenone application, which is 
compatible with experimental observations [40, 41] showing that uncouplers don’t affect 
ROS generation upon oxidation of NADH-linked respiratory substrates in the presence of 
rotenone. A strong increase in ROS production supported by different respiratory substrates 
at high ΔΨ is accounted for essentially by an increase in the concentration of the 
ubisemiquinone radical of Complex I (Fig. 3B), which has a very high ΔµH sensitivity, as 
observed experimentally [37, 38]. Consideration of the ubisemiquinone radical (complex 
CI.Q·− in Fig. 1) as an additional  generating site in Complex I is not supported by direct 
experimental observations although our computer simulation results and numerous 
experimental data [7, 9, 10] indirectly support this hypothesis. Elimination of this site in our 
computer simulation would disregard the ROS generation rate in the presence of succinate 
alone, i.e. during reversible electron transfer (RET), which would contradict experimental 
observations [6]. However, under certain special conditions of RET, e.g. upon inhibition of 
Complex III (Fig. 7C) or cytochrome c oxidase (Fig. 9C), oxidation of succinate alone 
results in inhibition of ROS production by the semiquinone of Complex I. Therefore, almost 
all superoxide in Complex I is generated by reduced FMNH− upon inhibition of Complex III 
(Fig. 7B) or cytochrom c oxidase (Fig. 9B). This results matches the properties of NADH− 
and RET-induced ROS production that were observed experimentally [79]. In this context, it 
should be also pointed out that ROS production is strongly inhibited by free fatty acids 
(FFA) in the presence of succinate alone [84]. These authors [84] noted that FFA have a 
dual effect, first, depolarization of the inner membrane due to their uncoupling effect and, 
second, partly blocking the respiratory chain, likely at the level of Complex III, and 
suggested that FFA decrease ROS generation during RET due to their uncoupling action. 
This is compatible with our modeling results presented in Fig. 3B that superoxide formation 
by the ubisemiquinone radical of Complex I, as the main ROS-producing site during RET, is 
strongly depressed upon depolarization of the inner membrane. In addition, we should point 
out that blocking Complexes III and IV also strongly depresses ROS production by the 
ubisemiquinone radical of Complex I (Fig. 7C and 9C) during RET. This suggests that the 
experimentally observed FFA inhibition of ROS production during RET could be accounted 
for both by depolarization of the inner membrane and by partly inhibition of the respiratory 
chain.
The sequential mechanism of QH2 oxidation with late dissociation of ISPH is more likely
Computer simulation of inhibition of Complex III by AA and myxothiazol in models with 
early [12] (model E) and late [11] (model L) dissociation of ISPH from cyt bL shows that 
model L is preferred for the following reasons. First, it is well known that AA induces an 
increase in the ROS production rate. Moreover, experimental observations [85] show that 
the uncoupler FCCP increases the AA induced ROS generation at the Qo site of complex III. 
This is not compatible with model E, in which AA induced ROS production drops to 0 at a 
low membrane potential. Besides, the computer simulated effect of inhibition of the second 
electron transfer in the Qo site (v24=0) on the ROS production rate fits the experimentally 
observed effect of myxothiazol and not that of stigmatellin. This conclusion is very 
important because model L has a FeS-lock mechanism to protect Complex III from short-
circuiting when both electrons transfer from QH2 into the high potential c-chain [13].
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Myxothiazol inhibits the second electron transfer in the Qo site
Computer simulated results presented in Fig. 7A,C support the hypothesis suggested by Yu 
and others [11] that myxothiazol inhibits transfer of the second electron from the 
ubisemiquinone radical to cyt bL. Inhibition of this step by myxothiazol has an effect on the 
ROS production rate that is identical to the effect of AA in model L (Fig. 5B,D) which is 
compatible with experimental observations of the myxothiazol effect on ROS production in 
liver mitochondria [71]. However, there are experimental observations in rat heart and brain 
[70] and insect muscle [86] mitochondria which showed a smaller increase in ROS 
production induced by myxothiazol alone than AA alone. Moreover, these observations 
show inhibition of the ROS production rate by myxothiazol in the presence of AA. One of 
the reasons for this may be inhibition of Complex I by myxothiazol [87]. Another reason 
may be competitive inhibition by myxothiazol of binding of quinol QH2p to the Qo site 
(reaction (22)) (see Supplementary Fig. S3).
ROS production by the ETC has a complex dependency on ΔΨ that varies with the 
concentration and nature of respiratory substrates and the presence of inhibitors
The generally accepted explanation that ΔΨ-dependencies of the rates of respiration and 
ROS production are reciprocal, i.e. that ROS production rates decrease upon depolarization 
of the inner membrane, does not give an accurate description of the complexity of the 
control of these processes. Under some conditions, e.g. for the FMNH− site with NADH as a 
substrate in the absence of rotenone, a high ROS production rate at a high ΔΨ can result 
from a more reduced carriers of ETC at the low respiration rate observed in state 4 
respiration. However, in general the situation will be more complex and an analysis of ΔΨ-
dependency of ROS production by different sites of ETC should be done separately for each 
site.
IMM depolarization of the inner mitochondrial membrane inhibits ROS production by both 
Complex I sites, FMNH− and CI.Q·− during oxidation of any substrates in the absence of 
inhibitors of the ETC (Fig. 3A, B). This is easy to understand because both these sites, 
FMNH− and CI.Q·−, are upstream of the potential-dependent transfer of four protons into the 
IMS in reaction (13). A high ΔΨ promotes an increase in their concentration at these sites, 
especially for the CI.Q·− site [37, 38]. Therefore, the concentration of these sites should 
decrease with decreasing membrane potential. However, during oxidation of Succ alone the 
steady state electron transfer in Complex I is close to equilibrium (apart from a minor 
deviation from equilibrium due to bypass reactions (16) and (17) of superoxide formation 
(Fig. 1, 2)). In this case, ROS production is maximal at high values of membrane potential. 
Addition of NADH stimulates forward electron transfer in Complex I with a transition from 
the near-equilibrium to the stationary state, resulting in a strong depression of ROS 
production at the CI.Q·−site(Fig. 3B, NADH+Succ).
The ΔΨ-dependency of ROS production by the unstable semiquinone of Complex III, the 
complex bL.Q·−.ISPH, is more complex and depends non-monotonically on the rate of 
oxidation of any substrates in the absence of inhibitors of the ETC (Fig. 3C). This is due to 
the following: In the absence of inhibitors of the ETC, the steady state rate of transfer of 
electrons through complex bL.Q·−.ISPH during oxidation of NADH, Succ or NADH+Succ 
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occurs mainly in the forward direction of reaction (24) with rate v24. This rate is 
approximately equal to the respiration rate (vresp), suggesting that the bypass reactions in 
Complex III are slow compared to the respiratory rate. Therefore, the concentration of 
complex bL.Q·−.ISPH is proportional to the respiration rate (since vresp ~ v24 ~ k24 · 
[bL.Q·−.ISPH] in the steady state). This implies that the steady state concentration 
[bL.Q·−.ISPH] adapts to the steady state respiratory rate, which strongly increases upon 
depolarization of the inner membrane (or is depressesed at high values of ΔΨ). For instance, 
compare simulated ROS formation at 100 ≤ ΔΨ ≤ 180 mV during oxidation of NADH+Succ 
in Fig. 3E. This is the main reason of the initial increase in computer simulated ROS 
production by Complex III upon depolarization of the inner membrane at 100 ≤ ΔΨ ≤ 180 
mV during oxidation of NADH+Succ in Fig. 3C. Further depolarization of the membrane 
below approximately 100 mV results in saturation of the respiratory rate (Fig. 3E, NADH
+Succ) and a decrease in ROS production by Complex III (Fig. 3C, NADH+Succ), which is 
due to a strong oxidation of the Q pool and a decrease in the concentration of complex 
bL.Q·−.ISPH. It should be noted that the ΔΨ-dependency of ROS production by the unstable 
semiquinone of Complex III, i.e., complex bL.Q·−.ISPH, during oxidation of Succ alone is 
almost monotonic and decreases upon depolarization. This is compatible with both 
experimentally observed [56] and computer simulated [23] results.
A comment on changes in the mitochondrial membrane potential
We analyzed steady state characteristics of ROS production in the electron transport chain 
under uninhibited conditions and upon inhibition of different segments of the respiratory 
chain at fixed values of the membrane potential. We did not consider explicitly alterations in 
membrane potential during inhibition of the respiratory chain. Alterations in the 
mitochondrial membrane potential in vivo depend on the activity of numerous electrogenic 
transport systems in the inner mitochondrial membrane such as Ca2+- and K+-channels, 
adenine nucleotide translocase, electrogenic H+ transport systems including H+ leak and H+ 
pumps of F0F1-ATPase and Complexes I, III and IV of the respiratory chain. Therefore, it 
would be expected that a decrease in the membrane potential occurs after inhibition of the 
respiratory chain and its H+ pumps unless ΔΨ is maintained by other reactions. However, 
real alterations in membrane potential are hard to assess because they depend on the activity 
of mitochondrial electrogenic transport systems apart from the electron transport chain. 
Therefore, we analyzed steady state ROS production over a wide range of ΔΨ in order to 
take into account any possible alterations in ΔΨ upon inhibition of the respiratory chain and 
extrapolated the rates of ROS production under different condition to any values of ΔΨ.
Testable predictions
In summary, the computational model developed here can be used to make experimentally 
verifiable and mechanistically sound predictions on the rates of ROS production at different 
sites of the electron transport chain. Our computational results predict that superoxide 
formation in Complex I during oxidation of succinate (RET) occurs predominantly at the 
semiquinone of Complex I, if no inhibitors of the respiratory chain are present (Fig. 3A–D). 
Therefore, inhibition of the flavin site of Complex I generally should not affect ROS 
production during succinate oxidation, i.e. during RET in the absence of any inhibitors of 
Complexes III and IV. By contrast, inhibitors of the flavin site should largely abolish ROS 
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production during RET in the presence of inhibitors of cytochrome c oxidase. The rate of 
ROS generation by the semiquinone of Complex I during RET can be quantified using 
inhibitors of both flavin and Q-binding sites of Complex I. In accord with our model, 
superoxide formation occurs only at the semiquinones of Complexes I and III in the 
presence of flavin site inhibitors (e.g., NADH-OH, ADP-ribose, DPI). The rate of ROS 
generation by Complex III during RET can be found in the presence of rotenone, the 
inhibitor of Complex I. Therefore, in order to find the ROS production rate generated by the 
semiquinone of Complex I during RET, the rate of ROS production in the presence of 
rotenone should be subtracted from the rate of ROS production in the presence of an 
inhibitor of flavin site. The model can similarly be used to predict the consequences for 
mitochondrial ROS production of changes in the expression level or activity of specific 
components of the electron transport chain e.g., as a consequence of signaling processes 
impacting respiratory complexes, or associated with specific disease conditions. 
Importantly, in our studies we focused on the ETC-dependent processes that generate 
superoxide. It should be emphasized that the net rate of ROS production in intact cells and 
tissues is strongly dependent on the activity of multiple oxidative stress defense mechanisms 
available both in the mitochondrial matrix and in other compartments in all cells. A detailed 
understanding of the balance of mitochondrial ROS production and its biological effects 
needs to take account of these and related antioxidant contributions to net ROS production 
(e.g., see [23]).
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Highlights
• Computational model of ROS production by the respiratory chain was 
developed.
• Semiquinone of Complex I should be considered to be an additional ROS 
forming site.
• Inhibition of Complexes III, IV reduces ROS production by Complex I 
semiquinone.
• Reduced iron-sulfur protein leaves the cyt b position only after cyt bH reduction.
• Depolarization activates ROS production by antimycin-inhibited Complex III.
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Fig. 1. Kinetic scheme of electron transfer and superoxide  production in the respiratory 
chain with early dissociation of ISPH in complex III
Dissociation of ISPH from cyt bL occurs in reaction (24). Reactions of  formation and 
utilization are shown by red arrows. The detailed reaction network is presented in Table 1.
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Fig. 2. Kinetic schemes of electron transfer and  production in complex III with late 
dissociation of ISPH
(A) All reactions are the same as in Fig. 1 except reactions (24) and (26). Dissociation of 
ISPH from the Qo site (reaction (26)) occurs later than in Fig. 1 in which ISPH dissociates 
during reaction (24). (B) Kinetic scheme of electron transfer with late dissociation of ISPH 
and additionally with binding of oxidized Q to the Qo site when cyt bL is reduced (reaction 
(41). All reactions are the same as in Fig. 2A except reactions (25), (25a), (26), (34a), (41), 
and (42).
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Fig. 3. Computer simulated stationary rate of respiration and  production at different 
membrane potential in the presence of different respiratory substrates
(A–C)) The rate of  generation by different sites of Complexes I and III: (A) site 
FMNH− of Complex I; (B) the semiquinone of Complex I (site CI.Q·−); (C) the unstable 
semiquinone of Complex III (site bL.Q·−.ISPH). (D) The total rate of  production by 
Complexes I and III. (E) The respiration rate. (F) The relationship between the rates of 
respiration and total  production by the entire respiratory chain when using different 
respiratory substrates. Computer simulation was carried out with the mathematical model at 
kinetic parameter values presented in Table 2. Different curves correspond to different 
respiratory substrates ± rotenone: black solid curve – NADH alone; blue dashed curve – 
succinate alone; red dash-dot curve – NADH + succinate; dark green dash-dot-dot curve – 
NADH + rotenone; cyan dotted curve – succinate + rotenone. Designation for every curve is 
also shown in the Figure. Different respiratory substrates correspond to the following 
parameter values: NADH alone -Vmax19 = 0, k15 = 0.45 s−1; succinate alone - Vmax19 = 
4270 µM/s; k15 = 0; NADH+succinate - Vmax19 = 4270 µM/s; k15 = 0.45 s−1. In order to 
simulate the effect of rotenone, we suggested that v8 = v14 = 0 in the computational model.
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Fig. 4. Computer simulation of the stationary  production rate and ubiquinol QH2n 
concentration at different values of proton motive force (expressed in mV) in the presence of 
succinate alone
(A) Solid black curves present changes in the total  production rate by Complexes I and 
III at different values of membrane potential (ΔΨ) and ΔpH = 0 (pHi = pHo = 7.5). Dashed 
red curves present the total  production rate at different values of ΔpH and ΔΨ=140 mV. 
Variation in ΔpH was made by introducing changes in pHo at constant pHi = 7.5. All 
parameter values are the same as for Fig. 3 except the rate constant of QH2 release in Qi site, 
k36 = 900 s−1. (B) Solid black and dashed red curves show ubiquinol concentration at the 
negative side of the membrane (QH2n) for the same conditions as for (A). (C) Simulation of 
the  production rate for the same conditions as for (A) except for the equilibrium 
constant of reaction (23) in Table 1, where exp(F · δ1 · ΔΨ/R · T + 2.3 · (7 – pHo)) was taken 
as 1 to make reaction (23) independent of ΔΨ and pHo. (D) Simulated  production rate 
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for the same conditions as for (A) except for the rate constant k36, which was decreased 
from 900 to 300 s−1.
Markevich and Hoek Page 37
Biochim Biophys Acta. Author manuscript; available in PMC 2016 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 5. Computer simulated effect of Antimycin A on the  production rate
(A, B) The total computer simulated superoxide production rate by Complexes I and III in 
models E (A) and L (B). (C, D) The rate of  generation by the unstable semiquinone of 
Complex III in models E (C) and L (D). Action of AA was simulated in the models by 
taking v34 equal 0 (see text for detail). Values of all parameters in the models without AA 
are the same as for Fig. 3 except k28 and k29 which equal 20 µM−1s−1. δ1 = 0.2 in both E and 
L models. Black solid curves correspond to the computer simulated  production rate in 
the control models and red dashed curves are the  production rates in the same models 
except for the rate v34 which was taken to be 0 to simulate the effect AA. Succinate alone 
was modeled as a respiratory substrate (Vmax19=4270 µM/s; k15=0)
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Fig. 6. Computer simulated partial inhibition of the  production rate by antimycin A
(A–E) Steady state dependency of the rates of respiration (A), total  production by 
Complexes I and III (B),  production by the reduced flavin of Complex I (C), the 
unstable semiquinone of Complex III (D), and the semiquinone of Complex I (E) on the rate 
constant k34 at different values of ΔΨ.
Relationship between rates of respiration and total  production (F) represents values of 
the rates from (A) and (B). Black solid curves correspond to the computer simulated rates at 
ΔΨ = 0; red dashed curves – ΔΨ = 50 mV; blue dash-dot curve −ΔΨ = 100 mV; dark green 
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dash-dot-dot curve – ΔΨ = 140 mV; cyan long-short-short dash – ΔΨ = 180 mV. All results 
were performed using the model L with NADH + succinate as respiratory substrates. All 
parameter values are the same as for Fig. 5. Vmax19 = 4270 µM/s; k15 = 0.45 s−1.
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Fig. 7. Computer simulated effect of inhibition of different reactions at the Qo site on the 
production rate during oxidation of succinate alone
(A–D) The computer simulated  production rate upon inhibition of the first (v23=0) or 
the second (v24=0) electron transfer in the Qo site of Complex III. (A) The total rate of 
generation by both Complexes I and III. (B–D) The rate of  generation by different sites 
of Complexes I and III: (B) the site FMNH− of Complex I; (C) the semiquinone of Complex 
I (complex CI.Q·−); (D) the unstable semiquinone of Complex III (complex bL.Q·−.ISPH). 
All computer simulations were performed using model E. Values of all parameters in the 
control model E are the same as for Fig. 5. Black solid curves correspond to the computer 
simulated  production rate in the control model E. Blue dash-dot and red dashed curves 
are the  production rates in the same model E, except for the rates v23 and v24 which 
were taken to be 0 to simulate the effects of stigmatellin or myxothiazol. Succinate alone 
was modeled as a respiratory substrate (Vmax19 = 4270 µM/s; k15 = 0).
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Fig. 8. Computer simulated effect of inhibition of cytochrome c oxidase on the  production 
rate during NADH oxidation
(A–D) The computer simulated  production rate at inhibition of cytochrome c oxidase 
(v40=0). NADH alone was simulated as substrate of respiration. (A) The total rate of 
generation by both Complexes I and III. (B–D) The rate of  generation by different sites 
of Complexes I and III: (B) the site FMNH− of Complex I; (C) the semiquinone of Complex 
I (complex CI.Q·−); (D) the unstable semiquinone of Complex III (complex bL.Q·−.ISPH). 
All computer simulations were performed using model L. Values of all parameters are the 
same as for Fig. 5. Black solid curves correspond to the computer simulated  production 
rate in the control model L and red dashed curves are the  production rates in the same 
model L except the rate v40 which was taken 0 to simulate the effect of inhibition of 
cytochrome c oxidase. Succinate alone was modeled as a respiratory substrate (Vmax19 = 
4270 µM/s; k15 = 0).
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Fig. 9. Computer simulated effect of inhibition of cytochrome c oxidase on the  production 
rate during succinate oxidation
(A–D) The computer simulated  production rate upon inhibition of cytochrome c oxidase 
(v40=0). Succinate alone was simulated as substrate of respiration. (A) The total rate of 
generation by both Complexes I and III. (B–D) The rate of  generation by different sites 
of Complexes I and III: (B) the site FMNH− of Complex I; (C) the semiquinone of Complex 
I (complex CI.Q·−); (D) the unstable semiquinone of Complex III (complex bL.Q·−.ISPH). 
All the computer simulations were performed using the model L. Values of all parameters 
are the same as for Fig. 5. Black solid curves correspond to the computer simulated ROS 
production rate in the control model L and red dashed curves are the  production rates in 
the same model L except rate v40, which was taken to be 0 to simulate the effect of 
inhibition of cytochrome c oxidase. Succinate alone was modeled as a respiratory substrate 
(Vmax19 = 4270 µM/s; k15 = 0)
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Fig. 10. Computer simulated effect of cytochrome c depletion on the  production rate during 
NADH alone oxidation
(A–D) The computer simulated  production rate at different cyt c concentration, [Cyt c]. 
NADH alone was simulated as substrate of respiration. (A) The total rate of  generation 
by both Complexes I and III. (B–D) The rate of  generation by different sites of 
Complexes I and III: (B) the site FMNH− of Complex I; (C) the semiquinone of Complex I 
(complex CI.Q·−); (D) the unstable semiquinone of Complex III (complex bL.Q·−.ISPH). All 
computer simulations were performed using model L. Values of all parameters are the same 
as for Fig. 5. Black solid curves corresponds to [Cyt c]=700 µM; red dashed curve - [Cyt 
c]=70 µM; blue dash-dot curve - [Cyt c]=10 µM; green dash-dot-dot - [Cyt c]= 0 µM. 
NADH alone was modeled as a respiratory substrate (Vmax19=0; k15=0.45 s−1)
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Fig. 11. Computer simulated effect of cytochrome c depletion on the  production rate during 
oxidation of succinate alone
(A–D) The computer simulated  production rate at different cyt c concentration, [Cyt c]. 
Succinate alone was simulated as substrate of respiration. (A) The total rate of 
generation by both Complexes I and III. (B–D) The rate of  generation by different sites 
of Complexes I and III: (B) the site FMNH− of Complex I; (C) the semiquinone of Complex 
I (complex CI.Q·−); (D) the unstable semiquinone of Complex III (complex bL.Q·−.ISPH). 
All the computer simulations were performed using model L. Values of all parameters are 
the same as for Fig. 5. Black solid curves corresponds to [Cyt c]=700 µM; red dashed curve 
- [Cyt c]=70 µM; blue dash-dot curve - [Cyt c]=10 µM; green dash-dot-dot - [Cyt c]= 0 µM. 
Succinate alone was modeled as a respiratory substrate (Vmax19 = 4270 µM/s; k15 = 0)
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Fig. 12. Computer simulated  production by antimycin-inhibited Complex III upon 
inhibition of succinate dehydrogenase during oxidation of succinate alone
(A) Dependence of the rate of  production on the maximal rate (Vmax19) of succinate 
dehydrogenase. (B) Dependence of the oxidized Q and reduced cyt bL fractions as well as 
the concentration of the bL.Q.ISPH complex on the maximal rate of succinate 
dehydrogenase. (C) Dependence of the rate of  production on the oxidized Q fraction. 
(D) Dependence of the rate of  production on the reduced cyt bL fraction. The rates v34 
and v34a were taken to be 0 to simulate the effect AA. All the computer simulations were 
performed with the model according to the kinetic scheme presented in Fig. 2B under steady 
state conditions. Values of all parameters are the same as for Fig. 9 except k26 = 1·104 s−1; 
Keq26 = 1·103 µM; k32 = 1.7 µM−1·s−1; k41 = k42 = 1·105 s−1; Keq41 = Keq42 = 1·103 µM; 
k25a = k34a = 1·105 s−1; Keq25a = Keq34a = 40; ΔΨ = 0. The oxidized Q fraction was 
calculated as 100% · ([Qn] + [Qp] + [bL−.Q.ISPH] + [bL.Q.ISPH])/[Qtot] and reduced cyt bL 
fraction as 100% · ([bL−.Q.ISPH] + [bL−.ISPH])/[bLtot].
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Table 1
Reactions and rate equations in the model of respiratory chain.
No Reaction Rate equation
Electron transfer in Complex I
1 NADH + FMN = FMN.NADH V1=k1 · ( NADH · FMN – FMN.NADH/Keq1)
2 FMN.NADH = FMNH−.NAD+ V2=k2 · ( FMN.NADH - FMNH−.NAD+/Keq2)
3 FMNH−.NAD+ = FMNH− + NAD+ V3=k3 · ( FMNH−.NAD+ - FMNH− · NAD+/Keq3)
4 FMN + NAD+ = FMN.NAD+ V4=k4 · ( FMN · NAD+ - FMN.NAD+/Keq4)
5 FMNH− + NADH = FMNH−.NADH V5=k5 · ( FMNH− · NADH - FMNH−.NADH/Keq5)
The first electron transfer
6 FMNH− + N3 = FMNH· + N3− V6=k6 · ( FMNH− · N3 – FMNH· · N3−/ Keq6)
7 N3− + N2 = N3 + N2− V7=k7 · ( N3−·N2 - N3·N2−/ Keq7)
8 CI + Qn = CI.Q V8=k8 · ( CI·Qn - CI.Q/ Keq8)
9 CI.Q + N2− = CI.Q·−+ N2 V9=k9 · ( CI.Q - CI.Q·− /Keq9)
The second electron transfer
10a FMNH· + N1a = FMN + N1a− + Hi+ V10=k10 · ( FMNH· · N1a – FMN · N1a− · exp(2.3 · (7-pHi)) / Keq10)
11a FMNH· + N3 = FMN + N3− + Hi+ V11=k11 · ( FMNH· · N3 – FMN · N3− · exp(2.3 · (7-pHi)) / Keq11)
12 N2 + N3− = N2− + N3 V12=k12 · ( N2 · N3− - N2− · N3/ Keq12)
13a N2−+ CI.Q·− + 8 · Hi+ = N2 + CI.QH2 + 6 · Ho+ V13=k13 · ( N2− · CI.Q·− · exp(2 · 2.3 · (7-pHi)) - N2 · CI.QH2 ·exp(4 · (F · ΔΨ/R · 
T + 2.3 · (pHi – pHo)))/Keq13)
14 CI.QH2 = CI + QH2n V14=k14 · ( CI.QH2 – CI · QH2n/Keq14)
NAD+ reduction to NADH in mitochondrial matrix
15 NAD+ = NADH V15=k15 · (NAD+ - NADH/Keq15)
Superoxide anion (O2·−mx) production by 
Complex I into the mitochondrial matrix
16 FMNH− + O2 = FMNH· + O2·−mx V16=k16 · (FMNH− · O2 - FMNH· · O2·−mx /Keq16)
17 CI.Q·− + O2 = CI.Q + O2·−mx V17=k17 · (CI.Q·− · O2 – CI.Q · O2·−mx /Keq17)
Superoxide anion dismutation in the mitochondrial matrix
18 2O2·−mx + 2Hi+ → O2 + H2O2 V18=Vmax18 · O2·−mx/(Km18 + O2·−mx)
Succinate dehydrogenase reaction (Complex II)
19b Succ + Qn → Fum +QH2n V19=Vmax19 · Qn/(Qn+QH2n)/(K19+Qn/(Qn+QH2n))
Q and QH2 intramembrane diffusion
20c QH2n = QH2p V20=k20 · ( QH2n - QH2p/Keq20)
21c Qp = Qn V21=k21 · ( Qp - Qn/Keq21)
Qo–site reactions (Complex III)
22 bL + ISPox + QH2p = bL.QH2.ISPox V22=k22 · ( bL·ISPox · QH2p - bL.QH2.ISPox/Keq22)
23a bL.QH2.ISPox = bL.Q·−.ISPH + Ho+ V23=k23 · ( bL.QH2.ISPox - bL.Q·−.ISPH · exp(F · δ1 · ΔΨ/R · T + 2.3 · (7 – 
pHo)) /Keq23)
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No Reaction Rate equation
24 bL.Q·−.ISPH = bL−.Q + ISPH V24=k24 · (bL.Q·−.ISPH - bL−.Q · ISPH/Keq24)
25a bL−.Q + bH = bL.Q + bH− V25=k25 · ( bL−.Q · bH− - bL.Q · bH− · exp(F · δ2 · ΔΨ/R · T)/Keq25)
26 bL.Q = Qp + bL V26=k25 · ( bL.Q - Qp·bL/Keq26)
27a ISPH + c1 = ISPox + c1− + Ho+ V27=k27 · ( ISPH · c1 – ISPox · c1−· exp(2.3·(7 – pHo)) /Keq27)
Superoxide anion (O2·−IMS) production by Complex III into the intermembrane space (IMS)
28 bL.Q·−.ISPH + O2 = bL.Q + ISPH + O2·−IMS V28=k28 · ( bL.Q·− .ISPH · O2 - bL.Q · ISPH · O2·−IMS /Keq28)
Superoxide anion (O2·−mx) production by Complex III into the mitochondrial matrix
29 bL.Q·−.ISPH + O2 = bL.Q + ISPH + O2·−mx V29=k29·( bL.Q·−.ISPH · O2 - bL.Q · ISPH · O2·−mx /Keq29)
Superoxide anion spontaneous dismutation and oxidation by cyt c in IMS
30 O2·−IMS + O2·−IMS → V30=k30 · (O2·−IMS)2
31 O2·−IMS + c = O2 + c− V31=k31 · (O2·−IMS · c – O2 · c−/Keq31)
Qi–site reactions (Complex III)
32 bH− + Qn = bH−.Q V32=k32 · ( bH− · Qn - bH−.Q/Keq32)
33a bH−.Q + Hi+ = bH.QH· V33=k33 · ( bH−.Q - bH.QH· · exp(F · δ3 · ΔΨ/R·T - 2.3 · (7 – pHi)) /Keq33)
34a bH.QH· + bL−.Q = bH−.QH· + bL.Q V34=k34 · ( bH.QH· · bL−.Q - bH−.QH· · bL.Q · exp(F · δ2 · ΔΨ/R·T)/Keq34)
35a bH−.QH· + Hi+ = bH.QH2 V35=k35 · ( bH−.QH· - bH.QH2 · exp(F · δ3 · ΔΨ/R · T - 2.3 · (7 – pHi)) /Keq35)
36 bH.QH2 = bH + QH2n V36=k36 · ( bH.QH2 - bH · QH2n/Keq36)
Cytochrome c reduction
37 c1− + c = c1−.c V37=k37 · ( c1− · c - c1−.c/Keq37)
38 c1−.c = c1.c− V38=k38 · ( c1−.c - c1.c−/Keq38)
39 c1.c− = c1 + c− V39=k39 · ( c1.c− - c1 · c−/Keq39)
Cytochrome c oxidase reaction (Complex IV)
40d 2 · c− + 4 · Hi+ + (1/2) · O2 = 2 · c + H2O + 2 · Ho+        V40 = k40 · c−/ctot/(1 + kO2/O2) ·
     (exp(−ΔG0/2 · R · T) · exp(2 · 2.3 · (7+pHo-2 · pHi)) ·
      exp(−ΔΨ · F/R · T) · O20.25 · c− - c · exp(ΔΨ · F/RT))
a
Reactions include steps dependent on membrane potential (ΔΨ) and/or inside (matrix) and/or outside (intermembrane space) H+ concentration, 
pHi and pHo, respectively. The dependence of equilibrium constant (Keq) of each of these reactions on ΔΨ were described as Keq(ΔΨ) = Keq · 
exp(n · F · δ · ΔΨ/R · T), where Keq is Keq at ΔΨ=0, n is number of electrons or H+ transferred through a part of the membrane δ. Other constants 
F, R, and T have usual meaning. The dependence of equilibrium constants on pH were described as in [21]: Keq(pH) = Keq · exp(2.3 · (7 – pH)), 
where Keq is Keq at pH = 7.
b
Rate equation was taken from experimental observations [88].
c
Diffusion process was described as in the paper [21].
d
Rate equation was taken from the theoretical work [26].
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1
pH
 =
 7
[6
2]
a
17
E(
Q/
Q·
−
) =
 −2
13
f
E(
O 2
/O
2·
−
)=
 −1
60
8.
3f
0.
04
f  µ
M
−
1 ·
s−
1
[6
2]
a
Su
pe
ro
xi
de
 a
ni
on
 d
ism
ut
at
io
n 
ca
ta
ly
ze
d 
by
 M
nS
O
D
 in
 th
e m
ito
ch
on
dr
ia
l m
at
ri
x
18
V
m
ax
18
 
=
 5
.6
 · 
10
4e
K
m
18
 
=
 5
0 
µM
[9
1]
[9
2]
Su
cc
in
at
e d
eh
yd
ro
ge
na
se
 re
ac
tio
n 
(C
om
ple
x I
I)
19
K
19
 
=
 0
.6
;
V
m
ax
19
 
=
 2
56
 m
M
/m
in
(42
70
 µM
/s)
[8
8]
Q 
an
d Q
H2
 tr
an
sm
em
br
an
e d
iff
us
ion
20
1
22
00
0 
s−
1
[2
1]
c
21
1
22
00
0 
s−
1
[2
1]
c
Q o
–
sit
e 
re
ac
tio
ns
 (C
om
ple
x I
II)
22
10
−
5  
f  µ
M
−
2
0.
1f  
µM
−
2 ·
s−
1
23
ΔE
m
 =
 −
20
0
m
V
 fo
r t
he
re
ac
tio
n
3.
4·
10
−
4
10
3  
s−
1
pH
o 
= 
7.
0
δ 1
 
=
 0
.2
[8
]ab
c
24
55
f  µ
M
10
5  
f  s
−
1
25
40
10
5  
f  µ
M
−
1  
s−
1
δ 2
 
=
 0
.5
[9
3]
b
26
10
6f  
µM
10
5  
f  s
−
1
27
E(
IS
PH
) =
 30
0
E(
c 1)
 = 
27
0
0.
3
10
5  
f  µ
M
−
1  
s−
1
pH
o 
= 
7.
0
[8
]ab
c
Su
pe
ro
xi
de
 a
ni
on
 (O
2·
−
IM
S) 
pr
od
uc
tio
n b
y C
om
ple
x I
II 
int
o t
he
 in
ter
me
mb
ra
ne
 sp
ac
e (
IM
S)
28
E(
b L
.
Q.
IS
PH
/ b
L.
Q·
−
IS
PH
) =
 −1
60
E(
O 2
/O
2·
−
) =
 −1
60
1
2 
µM
−
1 ·
s−
1
[2
1]
a
Su
pe
ro
xi
de
 a
ni
on
 (O
2·
−
m
x
) p
ro
du
cti
on
 by
 C
om
ple
x I
II 
int
o t
he
 m
ito
ch
on
dr
ial
 m
atr
ix
29
E(
b L
.
Q.
IS
PH
/b L
.
Q·
−
IS
PH
) =
 −1
60
E(
O 2
/O
2·
−
) =
 −1
60
1
2 
µM
−
1 ·
s−
1
[2
1]
a
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R
ea
ct
io
n
N
o
M
id
po
in
t
po
te
nt
ia
l
E m
=
E,
 (m
V)
Eq
ui
lib
ri
um
co
n
st
an
t
K
eq
k f
or
w
ar
d
O
th
er
 p
ar
am
et
er
s
R
ef
er
en
ce
Su
pe
ro
xi
de
 a
ni
on
 sp
on
ta
ne
ou
s d
ism
ut
at
io
n 
an
d 
ox
id
at
io
n 
by
 cy
t c
 in
 th
e i
nt
er
m
em
br
an
e s
pa
ce
 (I
M
S)
30
0.
6 
µM
−
1 ·
s−
1
pH
o 
= 
7.
0
[9
5]
c
31
E(
O 2
/O
2·
−
) =
 −1
60
E(
c) 
= 2
63
2.
2·
10
7
0.
26
 µ
M
−
1 ·
s−
1
[6
2]
a
 
[9
6,
 
97
]c
Q i
–
sit
e 
re
ac
tio
ns
 (C
om
ple
x I
II)
32
0.
02
2 
µM
−
1
2 
µM
−
1 ·
µs
−
1
[9
8]
bc
33
55
5·
10
4  
s−
1
pH
i =
 7
.5
δ 3
 
=
 0
.3
34
40
10
5  
f  s
−
1
δ 2
 
=
 0
.5
35
0.
67
10
5  
f  s
−
1
pH
i =
 7
.5
δ 3
 
=
 0
.3
36
45
 µ
M
27
0f  
s−
1
[9
8]
b
C
yt
oc
hr
om
e c
 re
du
ct
io
n
37
1.
17
2·
10
3  
µM
−
1 ·
s−
1
[9
9,
 
10
0]
bc
38
E(
c 1)
 = 
27
0
E(
c) 
= 2
63
0.
8
1.
4·
10
4  
s−
1
[9
4]
a
 
[9
9,
 
10
0]
c
39
0.
85
1.
71
03
 
s−
1
[9
9,
 
10
0]
bc
C
yt
oc
hr
om
e c
 o
xi
da
se
 re
ac
tio
n 
(C
om
ple
x I
V)
40
10
0f  
s−
1
[O
2] 
= 2
 µM
k O
2 
=
 1
 µ
M
;
ΔG
0  
=
 −
12
2.
94
 k
J·m
ol
−
1 ;
pH
i =
 7
.5
pH
o 
= 
7.
0
[2
6,
 
10
1]
a
R
ef
er
en
ce
 fo
r t
he
 m
id
po
in
t r
ed
ox
 p
ot
en
tia
l E
m
b R
ef
er
en
ce
 fo
r t
he
 e
qu
ili
br
iu
m
 c
on
sta
nt
 K
eq
c R
ef
er
en
ce
 fo
r t
he
 fo
rw
ar
d 
ra
te
 c
on
sta
nt
 k
fo
rw
ar
d
d V
al
ue
 u
se
d 
is 
co
m
pu
te
d 
fro
m
 th
e 
re
la
tio
n 
K
eq
1 
·
 
K
eq
2 
·
 
K
eq
3 
=
 e
x
p(2
 · F
 · (
E F
M
N
 
-
 
E N
A
D
+)
/R
 · T
) i
n a
cc
ord
 w
ith
 th
e t
he
rm
od
yn
am
ic 
cy
cle
 po
int
ed
 ou
t b
y K
us
sm
au
l a
nd
 H
irs
t [
28
], 
wh
ere
 m
idp
oin
t 
re
do
x 
po
te
nt
ia
ls 
E F
M
N
 
=
 −
38
0 
m
V
 (p
H 
7.0
) a
nd
 E
N
A
D
+ 
=
 −
32
0 
m
V
 (p
H 
7.0
), r
esp
ec
tiv
ely
, [3
2]
 an
d F
, R
 an
d T
 ha
ve
 us
ua
l m
ea
nin
g.
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e V
al
ue
 u
se
d 
is 
ca
lc
ul
at
ed
 fr
om
 e
xp
er
im
en
ta
l d
at
a 
on
 M
n-
SO
D
 a
ct
iv
ity
 w
hi
ch
 is
 a
ro
un
d 
of
 8
 U
/m
g 
m
it.
 p
ro
t. 
= 
80
00
 n
m
ol
/ m
in
/m
g 
m
it.
 p
ro
t. 
[9
1]
. S
o, 
V m
ax
18
 
n
o
rm
al
iz
ed
 b
y 
th
e 
m
at
rix
 v
ol
um
e 
is 
ca
lc
ul
at
ed
 in
 a
cc
or
d 
w
ith
 th
e 
fo
llo
w
in
g 
eq
ua
tio
n 
(se
e S
ec
tio
n 2
.2 
for
 de
tai
l):
 V
m
ax
18
 
=
 M
n-
SO
D
 a
ct
iv
ity
 · 
27
5 
µM
 /6
0 
s/W
m
x 
= 
5.
6 
· 1
04
 
µM
/s.
f V
al
ue
s a
dju
ste
d t
o m
atc
h e
xp
eri
me
nta
l d
ata
 on
 ki
ne
tic
s o
f s
up
ero
xid
e p
rod
uc
tio
n.
Co
ns
er
ve
d 
m
oi
et
ie
s (
nm
ol/
mg
 m
ito
ch
on
dri
al 
pro
tei
n):
 C
om
ple
x I
 co
nte
nt 
wh
ich
 ch
an
ge
s i
n d
iff
ere
nt 
tis
su
es 
fro
m 
0.1
 to
 0.
4 [
10
2,
 
10
3]
 w
as
 ta
ke
n a
s 0
.2 
nm
ol/
mg
 m
it.p
ro
t, v
alu
es
 of
 to
tal
 ub
iqu
ino
ne
 an
d 
Co
m
pl
ex
 II
I c
on
te
nt
 w
er
e 
ta
ke
n 
as
 fo
llo
w
s [
12
], 
[to
tal
 Q
] =
 4 
nm
ol/
mg
 m
it.p
rot
, [t
ota
l c
yt 
b L
] =
 [t
ota
l c
yt 
bH
]=
 [t
ota
l c
yt 
c 1
]=
 [t
ota
l I
SP
]=
0.3
25
 nm
ol/
mg
 m
it.p
ro
t, a
nd
 [t
ota
l c
yt 
c]=
70
0 µ
M
 [4
9]
. 
Tr
an
sla
tio
n 
of
 w
ho
le
 m
em
br
an
e 
co
nc
en
tra
tio
n 
ex
pr
es
se
d 
in
 n
m
ol
/m
g 
m
it.
pr
ot
. t
o 
lo
ca
l p
ro
te
in
 c
on
ce
nt
ra
tio
n 
ex
pr
es
se
d 
in
 µ
M
 p
re
se
nt
ed
 in
 S
ec
tio
n 
2.
2.
 T
he
re
fo
re
, t
ot
al
 lo
ca
l c
on
ce
nt
ra
tio
n 
of
 in
tra
m
em
br
an
e 
pr
ot
ei
ns
 h
av
e 
th
e 
fo
llo
w
in
g 
ap
pr
ox
im
at
e 
va
lu
es
 e
xp
re
ss
ed
 in
 µ
M
: t
ot
al
 Q
 = 
4 n
mo
l/ m
g m
it p
rot
 = 
45
41
 µM
; I
SP
 = 
cy
t b
L=
 c
yt
 b
H
=
 c
yt
 c
1=
0.
32
5 
nm
ol
/ m
g 
m
it 
pr
ot
 =
 3
69
 µ
M
; F
M
N
=N
3=
N
1a
=N
2=
0.
2 
n
m
o
l/ 
m
g 
m
it 
pr
ot
 =
 2
27
 µ
M
. T
he
 to
ta
l c
on
ce
nt
ra
tio
n 
of
 N
A
D
H
 w
as
 ta
ke
n 
30
00
 µ
M
 [2
5]
.
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Ta
bl
e 
3
R
O
S 
pr
od
uc
tio
n 
ra
te
s a
t d
iff
er
en
t s
ite
s o
f E
TC
 u
nd
er
 v
ar
yi
ng
 re
sp
ira
to
ry
 su
bs
tra
te
 a
nd
 in
hi
bi
to
r c
on
di
tio
ns
 in
 m
od
el
 L
.
In
hi
bi
to
r
In
hi
bi
te
d
re
a
ct
io
n
ra
te
 in
m
o
de
l L
(F
ig.
 2A
)
N
A
D
H
Su
cc
N
A
D
H
 +
 S
uc
c
FM
N
H
C
I.Q
·
−
b L
.
Q·
−
.
IS
PH
FM
N
H
C
I.Q
·
−
b L
.
Q·
−
.
IS
PH
FM
N
H
C
I.Q
·
−
b L
.
Q·
−
.
IS
PH
N
on
e
+
+
+
3A
+ 3B
+
+ 3C
≈0 3A
+
+
+
3B
+ 3C
+
+
+
3A
+ 3B
+
+
+
3C
R
ot
en
on
e
v
8 
=
 0
v
14
 
=
 0
+
+
+
3A
−
−
−
N
Sh
−
−
−
N
Sh
−
−
−
Ex
pc
t
−
−
−
Ex
pc
t
0
Ex
pc
t
+
+
+
Ex
pc
t
−
−
−
Ex
pc
t
−
Ex
pc
t
A
nt
im
yc
in
 A
v
34
 
=
 0
+
+
+
N
Sh
0 N
Sh
+
+
+
N
Sh
+
+
+
N
Sh
−
−
−
N
Sh
+
+
+
5D
+
+
+
Ex
pc
t
−
−
−
Ex
pc
t
+
+
+
Ex
pc
t
M
yx
ot
hi
az
ol
v
24
 
=
 0
+
+
+
N
Sh
0 N
Sh
+
+
+
N
Sh
+
+
+
7B
−
−
−
7C
+
+
+
7D
+
+
+
Ex
pc
t
−
−
−
Ex
pc
t
+
+
+
Ex
pc
t
St
ig
m
at
el
lin
v
23
 
=
 0
+
+
+
N
Sh
0 N
Sh
−
−
−
N
Sh
+
+
+
7B
−
−
−
7C
−
−
−
7D
+
+
+
Ex
pc
t
−
−
−
Ex
pc
t
−
−
−
Ex
pc
t
A
zi
de
, K
CN
v
40
 
=
 0
+
+
+
8B
0 8C
−
− 8D
+
+
+
9B
−
−
−
9C
−
− 9D
+
+
+
Ex
pc
t
−
−
−
Ex
pc
t
−
−
Ex
pc
t
Cy
t c
 
de
pl
et
io
n
+
+
+
10
B
0 10
C
−
−
10
D
+
+
+
11
B
−
−
−
11
C
+
/−
11
D
+
+
+
Ex
pc
t
−
−
−
Ex
pc
t
−
−
Ex
pc
t
IM
M
 d
ep
ol
ar
iz
at
io
n
−
− 3A
−
− 3B
+
/− 3C
−
− 3A
−
−
−
3B
+
/− 3C
−
− 3A
−
− 3B
+
/− 3C
*
Sy
m
bo
ls 
+,
 +
+,
 +
++
 a
nd
 −
, −
−,
 −
−−
 in
di
ca
te
 lo
w
, i
nt
er
m
ed
ia
te
, o
r l
ar
ge
 in
cr
ea
se
 o
r d
ec
re
as
e 
in
 R
O
S 
pr
od
uc
tio
n 
ra
te
, r
es
pe
ct
iv
el
y,
 c
om
pa
re
d 
to
 R
O
S 
pr
od
uc
tio
n 
ra
te
s u
nd
er
 u
ni
nh
ib
ite
d 
co
nd
iti
on
, o
r, 
fo
r 
th
e 
un
in
hi
bi
te
d 
co
nd
iti
on
, t
he
 c
ha
ng
e 
in
 R
O
S 
pr
od
uc
tio
n 
ra
te
 u
po
n 
ad
di
tio
n 
of
 re
sp
ira
to
ry
 su
bs
tra
te
.
*
*
Sy
m
bo
l +
/−
 in
di
ca
te
s v
ar
ia
bl
e 
ef
fe
ct
 d
ep
en
di
ng
 o
n 
m
em
br
an
e 
po
te
nt
ia
l.
*
*
*
N
Sh
, c
om
pu
te
d 
bu
t n
ot
 sh
ow
n;
 E
xp
ct
, n
ot
 c
om
pu
te
d 
bu
t e
xp
ec
te
d 
re
su
lts
.
*
*
*
*
3A
-1
1D
 re
fe
rs
 to
 th
e 
re
le
va
nt
 F
ig
ur
es
 in
 th
e 
te
xt
.
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